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ABSTRACT 
 
Synthesis of New, Single-Isomer Quaternary Ammonium Derivatives of β-Cyclodextrin 
for Electrophoretic Enantiomer Separations. (May 2006) 
Kingsley C. I. Nzeadibe, B.S., University of Oklahoma; 
M.S., Louisiana Tech University 
Chair of Adversory Committee: Dr. Gyula Vigh 
 
The isolation of individual enantiomers of drugs is an important subject of 
interest in the pharmaceutical and medical fields, because stereochemistry can have a 
significant effect on the biological activity of the drug.  Therefore, it is important to 
develop enantiomeric separation methods for the determination of the optical purity of 
drugs, since the undesired enantiomer is regarded as one of the impurities. 
The available single isomer anionic cyclodextrins (CD) can resolve the 
enantiomers of only a few weakly acidic analytes.  To rectify this problem, the chloride 
salts of heptakis(6-deoxy-6-morpholinio)-cyclomaltoheptaose (HMBCD), and mono(6-
deoxy-6-N,N,Nr,Nr,Nr-pentamethylethylenediammonio)-cyclomaltoheptaose 
(PEMEDA-BCD), the first members of the permanently charged, single-isomer cationic 
cyclodextrin family, have been synthesized.  The purity of process intermediates and 
final products was determined by HPLC-ELSD and indirect UV-detection capillary 
electrophoresis. Structural identity was verified by 1D and 2D NMR and mass 
spectrometry. 
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Both cationic CD derivatives have been used for the separation of the 
enantiomers of strong acid, weak acid, weak base, ampholytic, and neutral analytes by 
capillary electrophoresis.  Because the charge state of these cationic chiral resolving 
agents is independent of the pH of the buffer, separation could be performed in both low 
and high pH buffers without compromising the charge density of the resolving agent.  
Contrary to expectation, the multiply charged HMBCD showed poor complexation with 
the newly synthesized strong electrolyte test analytes.  The weak binding between the 
analytes and HMBCD resulted in separation of enantiomers of only three strong 
electrolyte analytes.  Strong complexation was observed between PEMEDA-BCD and 
the anionic and nonionic analytes in both low and high pH buffers, though complexation 
was stronger in the high pH buffer. Due to strong complexation between the anions and 
PEMEDA-BCD, only low concentrations of the resolving agent were required to effect 
good enantiomer resolutions.    
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CHAPTER I 
 
 
INTRODUCTION 
 
1.1 Chirality 
 
Chirality describes the relationship between two molecules that have the same 
atom to atom connectivity, but are non-superimposable.  These molecules are mirror 
images, and are called enantiomers.  The isolation of individual chiral forms of drugs is 
an important subject of interest in the pharmaceutical and medical fields, because 
stereochemistry can have a significant effect on the biological activity of the drug [1].  
There is a large number of currently used drugs that contain at least one chiral center, 
and one enantiomer of a given drug may not have equivalent therapeutic value, or 
potentially could cause unwanted side effects relative to the other enantiomer [1,2].  
Enantiomers of pharmaceuticals have been predominantly separated by 
chromatographic techniques such as GC, HPLC and SFC [3-6].  The limitation of GC to 
volatile compounds gives the liquid chromatographic techniques advantage over the 
former.  SFC has shown distinct advantage over HPLC due to the higher separation 
efficiencies and shorter run times observed in SFC.  Currently, the most powerful 
method for separation of drug enantiomers is CE, owing to its high separation efficiency 
in small diameter capillaries [7-11]. 
 
This dissertation follows the style and format of Journal of Chromatography A. 
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1.2 Principles of Capillary Electrophoresis  
In CE, charged molecules migrate under the influence of an electric field, with a 
certain electrophoretic velocity, <.  This velocity is proportional to the electric field 
strength, E. 
< = :+        (1) 
The magnitude of the proportionality factor, :, the mobility, is dependent on the charge 
of the separand, and the frictional drag: 
   : = z/6B0r,        (2) 
where z is the charge of the ion, 0 is the viscosity of the buffer solution (background 
electrolyte, BE), and r is the hydrated ionic radius of the separand.  Separation in CE is 
achieved by differences in the electrophoretic mobility of charged molecules. 
During electrophoresis, there is partial dissociation of the silanol groups at the 
surface of the fused silica capillary in contact with the BE.  The extent of the 
dissociation of the silanol groups depends on the pH of the BE.  Thus, immobilized 
negative charges are created on the inner wall of the capillary.  In order to establish 
electroneutrality, some of the positive ions in the BE are strongly attracted to the wall, 
thus a compact or Stern layer is formed.  The remaining cations from the BE are loosely 
held further out in the diffuse or Gouy-Chapman layer. Therefore, a double layer is 
created with a shear plane between the two layers.  The potential at the shear layer is 
known as zeta potential.  When voltage is applied along the length of the capillary, the 
solvated cations in the diffuse layer migrate toward the cathode at a constant velocity, 
dragging along with them solvent molecules.  Thus, a bulk flow of the BE, 
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electroosmotic flow, is obtained in the capillary.  However, differential adsorption of 
positively charged molecules from the BE can cause the silica surface to acquire positive 
charges [12].  In this case the bulk flow will migrate toward the anode, and its magnitude 
is dependent on the concentration of the adsorbing molecule. 
The electroosmotic velocity (νeo), depends on the permittivity of the medium (ε), 
the dielectric constant (ε0), the zeta potential (ξ), the dynamic viscosity of the medium 
(η), and the applied electric field (E): 
  νeo  =  -ξε0εE/η = :eo+      (3) 
The negative sign is an indication of the direction of flow, to the cathode.  
When the thickness of the double layer (which is a reciprocal of the Debye-Huckel 
parameter, 1/k), is much smaller than the radius of the capillary, r, a plug flow profile is 
obtained for the bulk flow [12].  When the thickness of the double layer is about equal to 
the inner radius of the capillary, the electroosmotic velocity is much reduced, and 
consequently, the flow profile becomes parabolic [12, 13].  During a CE run the 
electroosmotic flow can carry cations, anions, and uncharged molecules in the same 
direction, past the detector, allowing them to be detected.  Therefore, charged molecules 
migrate with the combination of the non-selective EOF mobility and their effective 
mobility, µeff.  This sum is defined as the observed mobility, µobs: 
   µobs = µeff + µeo       (4) 
The effective mobility of the separand is dependent on the ionic strength of the BE, and 
for an organic ion with a charge, z, it can be expressed by the equation: 
 4
 
 
 
  2/1
0
))(77.0exp( zI
eff
−=µ
µ       (5) 
 where :0 is the ionic mobility at infinite dilution.  The ionic strength of the BE, I, is 
defined as 
  I = 1/2Gcz2        (6) 
where c, is the concentration the ionic species of the BE. 
Because of the flat flow profile of EOF, and efficient heat dissipation in the 
capillary, CE offers a greater separation efficiency (over 1 million theoretical plate) than 
the pressure-driven methods, in which the flow profile is parabolic. As an analytical tool, 
CE has developed rapidly as one of the most powerful techniques for separation of a 
wide range of compounds including enantiomers.  This is as a result of its speed of 
analysis, low operating cost, and the ease of modifying the BE with additives to improve 
separation selectivity. 
 
1.3 Enantioresolution and Cyclodextrins 
Enantiomers of a chiral compound can not be resolved without a chiral selector 
since both the EOF and the effective mobility of the analyte are identical for the 
enantiomers [14,15].  What may distinguish enantiomers in a chiral CE is their 
differential interaction with a chiral selector that leads to formation of diastereomeric 
complexes in a dynamic equilibrium process.  If the complexation constants of the 
enantiomers with the chiral selector or the ionic mobilities of the diastereomeric 
complexes are different, then, enantiomer separation in CE can be obtained. 
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Among the different chiral selectors used in CE, cyclodextrins (CD) are the most 
popular [16].  This can be attributed to their previous successful applications in GC and 
HPLC [17-19], their ability to differentially interact with a large number of analytes, and 
their relatively high water solubility [20-23].  CDs are chiral, neutral, cyclic 
oligosaccharides composed of glucopyranose units connected to each other through "-
(1-4) glycosidic linkages, and having the shape of a hallow, truncated cone.  There are 
two generally accepted requirements for chiral recognition of enantiomers by CDs in CE 
separation.  First, the analyte must have a proper structural fit, which can result in the 
formation of inclusion complexes.  Secondly, the groups on the rim of the CD cavity 
must interact with a substituent group near or on the stereogenic center of the molecule 
[24].  Differences in the properties of the diastereomeric complexes, especially their 
hydrodynamic volume, enable the separation of the enantiomer by CE.  
Properties of the parent cyclodextrin can be modified by replacement of one or 
more of the primary or secondary hydroxyl groups with suitable moieties.  These 
derivatized CDs can provide potentially useful interaction sites, and unique selectivity 
for CE separations by altering the charge and solubility of the native cyclodextrin.  
Derivatization of the hydroxyl groups present at the rim may also cause changes in the 
size and depth of the cyclodextrin cavity [25].  Since the only restriction to derivatization 
of cyclodextrins is the type and number of functional groups that can be substituted on 
the hydroxyl groups on the rim of CD, a large and diverse group of derivatized 
cyclodextrins is available now.  
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Derivatized cyclodextrins that are commonly used in CE can be classified as 
neutral, anionic, cationic, and zwitterionic.  Monosubstituted, polysubstituted, and 
persubstituted cyclodextrins are now available.  The degree of substitution of the 
cyclodextrin derivative has been shown to have significant effect on the resolution of the 
enantiomers [26,27 and 28].  For example, hydroxypropyl-derivatized cyclodextrins and 
methylated cyclodextrins are commercially sold as mixtures of isomers, but are not 
labeled as such [28].  Other neutral, derivatized cyclodextrins such as 
naphthylethylcarbamoylated [29], and mono-3-O-phenylcarbamoylated cyclodextrins 
are available for chiral CE separation.  The major problem with neutral CDs, like with 
the native CDs, is that they can only be used for the separation of charged analytes. 
In the last few years, CDs bearing charged functional groups have aroused great 
interest for the following reasons.   (i) Only charged analytes may be resolved in CE 
with neutral CDs, whereas charged CDs allow the separation of neutral analytes as well 
as charged ones [30-33].   (ii) Being more soluble in water, it is possible to obtain highly 
concentrated solutions in the background electrolyte (BE).   (iii) The guest-host 
electrostatic interactions between the oppositely charged selectors and selectrands 
increase the stability of the inclusion complexes, and alter the selectivity in the host-
guest interaction [33]. 
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1.4 Single-isomer Charged Cyclodextrins 
Some anionic and cationic CDs are commercially available, generally as 
mixtures of randomly derivatized components with different degrees of substitution. 
Obviously, random substitution produces a number of isomers that leads to batch-to-
batch variations in the composition of the mixture.  Because each CD isomer has a 
unique binding characteristics for a given enantiomer pair, it is difficult to predict the 
outcome of interactions with a particular analyte [34].  This complexity creates difficulty 
in performing a systematic study of chiral CE separations, and prevents the development 
of a molecular-level separation.  Therefore, it is necessary to synthesize single-isomer 
substituted CDs that will allow a better understanding of the different factors involved in 
enantiorecognition. 
Selectively modified anionic [35,36], and cationic CD derivatives have been 
synthesized which allow good understanding of the different factors involved in the 
chiral recognition process [37, 38].  Single-isomers sulfated "-, $-, and (-CDs have 
recently been synthesized, and characterized by both NMR and mass spectrometry [39-
48].  Each of these single-isomer CDs has been effectively used to separate some 
cationic enantiomers, and the results obtained are in agreement with the predictions of 
the Charged Resolving Agent Migration (CHARM) model [49]. 
The secondary equilibra-based CHARM model was introduced specifically to 
simplify the development of chiral CE separation methods by determining resolution and 
separation selectivity as a function of the concentration of the charged single-isomer 
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chiral selector (CCD) and pH of the BE.  For a 1:1 complex between the CCD and the 
analyte, the resulting effective mobility of one of the enantiomers can be written as: 
 
][1]([][1
][]([][
3
00
3
00
CDKOHKCDK
CDKOHKCDK
HRCDRCD
HRCDHRCDHRRCDRCDReff
R +++
+++= µµµµµ   (7) 
 
where :oR and :oRCD, :o HR and :oHRCD are the ionic mobilities of the uncomplexed and 
fully complexed species, KRCD and KHRCD are the complexation coefficients for the  non-
protonated and the protonated forms of the enantiomer complexes, K is the acid 
dissociation constant for the enantiomer, and [H3O] and [CD] are the concentrations of 
the hydronium ion and the resolving agent.  For a given enantiomer pair, the separation 
selectivity, ", obtained at a particular CD concentration is: 
 eff
eff
2
1
µ
µα =         (8) 
The peak resolution expression for an ideal CE system with longitudinal diffusion as the 
major contributor to peak dispersion [49] is described as: 
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where l is the length of the capillary, eo is the electric charge, k is Boltzman’s constant, T 
is the absolute temperature, zeff is the effective charge of the analyte complex,  α is the 
separation selectivity.  The normalized electroosmotic mobility ($), which is given by 
the expression :eo / :2eff can easily be adjusted to obtain better resolution for the 
enantiomer separations so long as " is not equal to unity.  The subscript 2 refers to the 
slower of the two migrating enantiomers.  
According to the CHARM model, peak resolution for weak electrolytes depends 
on the pH of the BE.  This leads to three types of enantiomer separations using CCDs: 
desionoselective, ionoselective, and duoselective separations.  For desionoselective 
separation of weak acids and ionoselective separation of weak bases, peak resolution is 
high at low pH.  For ionoselective separation of weak acids, and desionoselective 
separation of weak bases, peak resolution is high at high pH. For duoselective separation 
of both weak acids and weak bases, resolution is high at both low and high pH.  On the 
other hand, peak resolution values for both neutral and strong electrolyte analytes are 
similar at all pH values.  From a practical point of view, the most efficient approach to 
developing a rugged method for chiral CE separations is the use of two BEs: one at low 
pH, and the other at high pH [49].  It is important to note that the development of 
enantiomer separations lies in optimizing the $ term through the use of coated capillaries 
and /or appropriate background electrolyte constituents.  By optimizing $ and knowing 
the dependence of ", z1eff, and z2eff on the composition of the BE, resolution can be 
achieved.  According to equation 9, when all other parameters are equal, resolution 
increases with the square root of z.  Therefore, under identical conditions, increase in the 
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zeff will lead to increase in resolution.  Thus, the three-dimensional resolution surface in 
Figure 1 demonstrates that, under identical ", and $ conditions, resolution increases with 
the effective charge.  When $ and zeff are constant, resolution increases linearly with ".  
Under identical " and z, resolution increases towards infinitely high value as $ 
approaches –1.  As long as the cyclodextrin shows some selectivity for the enantiomers, 
one can improve resolution by optimizing $, though this comes at the expense of 
increased analysis time. 
 
1.5 Enantioseparation with Cationic Cyclodextrins 
More anionic than cationic CDs are currently used in chiral CE separations, and 
the available single-isomer anionic CDs can only resolve few of the anionic analytes.  
Most of the previously synthesized cationic cyclodextrins were not often used for 
separation of enantiomers in CE.  For example, an amino-functionalized cyclodextrin 
was used as a model for studying enzymatic biological processes involving a positively 
charged group in the vicinity of the active site [50]. Mono-6-(alkylamino)-$-
cyclodextrins [51, 52] were used to study the degree of cooperative binding between 
organic quest and aggregated amphipathic cyclodextrins. Recently, three positional 
isomers of $-cyclodextrin derivatives bearing two trimethylammonio groups on two of 
the C-6 atoms of cyclodextrin [53,54], were made by alkylation of the corresponding 
regioisomers of diamino $-CD compounds [55] with methyl iodide in the presence of 
potassium hydrogen carbonate.  However, these cationic CDs were not used for chiral  
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Figure 1.  Peak resolution surfaces for 7-charged and 14-charged cyclodextrins as a 
fuction of separation selectivity and normalized electroosmotic flow. 
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CE separation studies.  Rather chiral guest recognition was performed by calorimetric 
studies using the regioisomer, quaternary ammonio CDs. 
The earliest cationic cyclodextrin derivative that was used for CE separation was 
the mono-(6-$-aminoethylamino-6-deoxy)-$-cyclodextrin [37].  However its use was 
limited to the separation of a few dansylated amino acid.  Following this, some 
monosubstituted, strong electrolyte, and weak electrolyte, cationic CDs have been 
synthesized and applied to CE enantiomer separations [56-67]. Typically, these 
monocationic, single-isomer CDs are prepared from CD intermediates bearing a good 
leaving group such as tosyl and iodo, at carbon six of one of the glucose units.  The final 
products are obtained by reaction of the intermediates with an amine or quaternary 
ammonium group under suitable conditions (usually at elevated temperature).  For 
example, 6A-methylamino-$-cyclodexrin was synthesized through tosylated $-
cyclodextrin intermediate [54], followed by substitution of the tosyl group with 
methylamine [68].  Enantiomers of 2-hydroxy acids (mandelic acid, MA, m-
hydroxymandelic acid, m-MA, p-hydroxymandelic acid, p-MA, and 3,4-di-
hydroxymandelic acid, 3,4-di-MA) were separated by Nerdi et al., using the 6A-
methylamino-$-cyclodexrin [69].  It was found from these studies that all the 
compounds migrated anodically on a bare fused silica capillary, and the order of 
complexation was p-MA > MA > 3,4-di-MA > m-MA.  3,4-di-MA and m-MA showed 
lesser complexation with the cationic CD because of the hindering effect of the OH 
group on the aromatic ring. 
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Dicationic CDs have also been synthesized and used for separation of 
enantiomers by CE.  For example, 6-ethylenediamine-derivatized -$-cyclodextrin was 
effectively used to separate some anionic compounds [70].  Under the conditions the CD 
was used, cathodic EOF was observed, and all the analytes were detected at the cathode.  
All the analytes separated, contained at least one aromatic ring and a carboxylic acid 
functionality.  Also, in most cases, the carboxylic acid group was one of the groups at 
the chiral center, which lies within one to two bond distances from the aromatic ring. 
Selectively modified 6,6’-didoexy-6,6’-diamino-cyclodextrins, having the amine group 
directly attached onto two glucose units of the cyclodextrins have been prepared, and 
used for separation of enantiomers of hydroxy acids, and carboxylic acids [71].   The 
relative distance between the two positive charges on the rim of these cationic CDs 
greatly influenced their enantio-recognition ability.  For a dicationic CD derivative, there 
is an optimum distance between the two charges that leads to good enantiomer 
separation.  Selectively functionalized, dicationic CD, 6-deoxy-6-(N-histamino)-$-
cyclodextrin, bearing a histamine moiety linked to the C-6 atoms of a glucose unit via 
the amino group, was synthesized by treating mono substituted iodo-$-CD with 
histamine under very harsh conditions [72].   Following a similar synthetic method, its 
analog, 6-deoxy-[4-(2-aminoethyl)imidazolyl]-$-cyclodextrin, bearing the histamine 
moiety linked to the C-6 atoms via the imidazolyl group was also synthesized [73]. Both 
CDs have been used for the separation of enantiomers of dansylated amino acids, 
hydroxy acids, and carboxylic acids [74, 75].  Here again the pKa of the protonated 
groups varied according to the relative distance from the CD cavity, and as a 
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consequence the two chiral selectors exhibited different enantiorecognition 
characteristics.  The effect of pH on selectivity and resolution was studied for both CDs 
in the range of 4.0 to 9.0.  Because of the differences in the pKa values of the protonated 
groups, the number of net positive charges on the CDs changed as the pH of the BE was 
varied.  As the pH value increased, selectivity decreased, and after pH 7.5, there was 
practically no separation of the enantiomers.  The best enantioseparation was observed at 
pH 5. 
Using either pertosylated or perhalogenated CDs [76,77] as precursors, a few 
primary, secondary and persubstituted, amino CDs have been synthesized [78-83]. 
Heptakis(6-deoxy-6-methoxyethylamine)-$-cyclodextrin was used to separate the 
enantiomers of non-steroidal, anti-inflamatory drugs (NSAID), and phenoxy propionic 
acids [84].  The positively charged CD did not only cover the inner wall of the bare 
fused silica capillary, but also produced a reversed, stable EOF under the conditions it 
was used. It was also observed that in addition to the ionic and hydrogen-bonding 
contributions to chiral recognition, steric interactions also contributed to the overall 
complexation between the multiply charged CD and the NSAIDs [84].  At pH 5, where 
the CD was fully protonated and the analytes were all anionic, no separation of the 
enantiomers of ketoprofen was observed.  However, the enantiomers of suprofen which 
is structurally similar to ketoprofen were resolved at pH 5.  It was noted that the 
propionic acid moiety of suprofen is in the para position while that of ketoprofen is in 
the meta position indicating that suprofen can more favorably orient within the cavity of 
the CD than ketoprofen [84].  Here again it was observed that the EOF, the charge, and 
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the chiral recognition properties of both the analytes and the CD depended on the pH of 
the BE.        
Two randomly substituted, commercially available, quaternary ammonium $-
CDs have been used for the separation of the enantiomers of various acidic analytes 
[70,85].  A quaternary ammonium $-CD, having the quaternary groups linked to the C6 
atoms through a 2-hydroxypropylene ether, and quaternary ammonium hydroxypropyl 
$-CD, having the quaternary ammonium group directly attached to the C6 atoms are sold 
commercially as multiple-isomer CDs.  When compared to neutral CDs, both CDs were 
effective for the separation of enantiomers at low CD concentrations due to the strong 
electrostatic interaction between the cationic CDs and anionic analytes.  Following a 
similar synthetic scheme, some other randomly substituted quaternary ammonium CDs 
have been made, and used for the separation of racemic mixtures [86].  The best 
advantage of this set of chiral selectors is that they allow for the adjustment of the pH of 
the BE according to the requirements of the particular analyte because the charges on the 
CDs are independent of the pH of the BE.  However, because they consist of multi-
components having different degrees of substitution, good reproducible enantiomer 
separations are more difficult to obtain with them. 
From the foregoing analysis of CE enantiomer separation, it is clear that having a 
system in which the effective mobilities of the uncomplexed analyte and the complexed 
analyte have opposite signs will be most desirable as predicted by the CHARM model 
[49].  From the practical point of view, it is also desirable to have systems in which the 
pH of the BE can be freely adjusted, according to the type of the separation involved 
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(desionoselective, ionoselective or duoselective separation [49]), without changing the 
charge state of the resolving agent used.  For the anionic analytes, multiply charged, 
quaternary ammonium CDs would be preferable. 
In order to satisfy these requirements, the objective of this dissertation is to 
synthesize cationic cyclodextrins that are (i) single-isomers, (ii) multi-cationic 
derivatives that carry (iii) closely spaced, (iv) permanent charges and (v) can be made 
readily available in large quantities to permit their widespread use in CE. Since most 
anionic analytes of interest are single-charged, the lowest and highest charge numbers on 
the permanently cationic, single-isomer, resolving agent that fulfill this requirement are 
two and seven respectively, in the case of beta cyclodextrin. Therefore, this dissertation 
will discuss the synthesis, analytical characterization of heptakis(6-deoxy-6-
morpholinio)-cyclomaltoheptaose (HMBCD), and mono(6-deoxy-6-N,N,N’,N’,N’-
pentamethylethylenediammonio)-cyclomaltoheptaose, (PEMEDA-BCD), and their 
applications in capillary electrophoretic separation of enantiomers. 
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CHAPTER II 
 
SYNTHESIS AND CHARACTERIZATION  
 
A very small number of anionic chiral compounds have been resolved with the 
available single-isomer sulfated cyclodextrins.  In this work, the first single-isomer, 
persubstituted quaternary ammonium $-CD, the chloride salt of heptakis(6-deoxy-6-
morpholinio)-cyclomaltoheptaose (HMBCD), and the first single-isomer, quaternary 
diammonio $-CD, the chloride salt of mono(6-deoxy-6-
pentamethylethylenediammonio)-cyclomaltoheptaose (PEMEDA-BCD) have been 
synthesized on a large scale and analytically characterized. 
 
2.1 Materials and General Methods 
All chemicals used in this work were purchased from Aldrich Chemical 
Company (Milwaukee, WI, USA), except native $-CD, which was purchased from 
Cerastar (Cedar Rapids, IA). Progress of the reaction for the $-CD intermediates was 
monitored by thin layer chromatography (TLC), using Silica-60 plates (E. M. Science, 
Gibbstown, NJ). The developed plates were visualized by dipping them into an ethanolic 
"-naphthol staining solution (made by combining 26.25 g of "-naphthol, 315 mL of 
100% ethanol, 105 mL of concentrated sulfuric acid, and 66 mL of distilled water) and 
heating for 10 min at 100oC.  The purity of the intermediates was determined by 
analytical isocratic HPLC using a system containing a Programmable Solvent Module 
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126 (Beckman-Coulter, Fullerton, CA), a Sedex Model 55 evaporative light scattering 
detector (S.E.D.E.R.E., Alfortville, France), and an AD 406 data acquisition system 
operated under Gold 8.1 software control (Beckman-Coulter) running on a 486DX4 
personal computer (Computer Associates, College Station, TX). The separations were 
obtained on a 4.6 mm I. D. × 250 mm column packed with a 5:m Zorbax ODS 
stationary phase (Agilent, Newport, DE). The purity values reported in this dissertation 
were calculated with the assumption that the response factors of the evaporative light 
scattering detector were the same for all CD isomers. Since the products of the amination 
and quaternarization reactions are charged, the progress of these reactions, and the purity 
of $-CD derivatized with morpholine, and that of the quaternary ammonio $-CD were 
determined by indirect UV-detection CE, using a P/ACE 2000 system (Beckman-
Coulter), at 214 nm and 10 kV applied potential, on a 26.4 / 19.6 cm long, 25 :m I. D. 
bare fused silica capillary column (Polymicro Technologies, Phoenix, AZ). The cartridge 
coolant of the P/ACE 2000 was thermostated at 20oC. 
The molecular mass of the intermediates was obtained by high resolution 
MALDI-TOF-MS. A Voyager Elite XL TOF mass spectrometer equipped with delayed 
extraction capability (PerSeptive Biosystems, Framingham, MA) in reflectron mode, 
with an acceleration voltage of 25 kV, 70% grid voltage, 0.035% guide wire voltage, and 
a delay time of 180 :s, was used to collect the high-resolution mass spectra. The 
analytes were spotted onto a Teflon target using the dried droplet method [87]. The 
matrix was prepared by dissolving 10 mg 2,4,6-trihydroxyacetophenone in 1 mL 
acetonitrile [88].  The molecular mass of the final products, HMBCD and PEMEDA-
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BCD was obtained by ESI-TOF-MS with a Vestec Model 201-A single quadrupole mass 
spectrometer equipped with a Vestec electrospray ion source (PerSeptive Biosystems). 
The sample was prepared at a concentration of 4 mg/mL in an acetonitrile : water 1:1 
(v/v) solvent mixture.  1H and 13C NMR spectra were measured on UnityPlus 300 and 
500 spectrometers with a quad nucleus (1H / 13C  /19F / 31P) probe, operated under Solaris 
2.4 and Vnmrx 5.3 b software control. The proton (H) and carbon (C) assignments were 
based on the 1H-1H 2D COSY (Correlation Spectroscopy), 1H-13C HETCOR NMR 
(Heteronuclear Correlation Spectroscopy), and 1H-13C HMQC (Heteronuclear 
Correlation Through Multiple Quantum Coherence) experiments. 
 
2.2 Synthesis and Characterization of HMBCD 
The synthesis scheme used for preparation of heptakis(6-deoxy-6-morpholinio)- 
cyclomaltoheptaose (HMBCD) is shown in Figure 2. The details of the synthetic 
procedures are outlined in the Appendix. 
 
2.2.1 Heptakis(6-deoxy-6-iodo)- $-cyclodextrin 
Selective substitution of the hydroxy groups at the primary positions of native $-
CD with iodine was performed, as reported in the literature [89, 90], by direct 
halogenation with bromine or iodine, in the presence of triphenylphosphine (Ph3P) and 
DMF [91]. 
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Thus, native $-CD (1) was treated with I2 and Ph3P in DMF at 70 °C for 18 hours 
to obtain heptakis(6-deoxy-6-iodo)-$-CD, intermediate compound (2). Because the 
reported workup procedures that used either water to precipitate the product or Soxhlet 
extraction to clean up the product, did not yield a pure product, a recrystallization 
method involving a DMF/water mixture was developed and used to obtain intermediate 
compound (2).  The progress of the purification process, and the purity of intermediate 
compound (2) was monitored by isocratic aqueous reversed phase HPLC, using a 4.6 
mm I.D. × 250 mm Zorbax C18 column and a 95: 5 CH3OH: water mobile phase at 1.8 
mL/min at 45 °C.  Intermediate compound (2) was obtained with an isomeric purity > 
99% at 65% yield for a 46 g scale.  Figure 3 shows the chromatograms obtained by 
aqueous, reversed-phase HPLC separation of intermediate compound (2) before and 
after recrystallization from the DMF/water mixture.  Figure 4 shows the 1H NMR 
spectra of intermediate compound 2 before and after recrystallization from the 
DMF/water mixture. 
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Figure 2.  Synthesis scheme for heptakis(6-deoxy-6-morpholinio)-β-cyclodextrin 
chloride (HMBCD). 
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Figure 3.  Chromatograms of intermediate compound (2).  (A) before recrystallization, 
(B) after recrystallization.  Conditions: RP HPLC, C-18, 95 : 5 CH3OH : H2O.  Flow rate 
= 1.8mL/min at 45°C. 
 
B
A
Time / min
Target
A
bs
or
ba
nc
e 
/ A
U
0.0 5.0 10.0 15.0
-0.010
-0.005
0.000
0.005
0.010
0.015
0.020
0.025
 23
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.  1H NMR spectra in DMSO-d6, using a 500 MHz NMR spectrometer, during 
purification of intermediate compound (2).  (A) reaction mixture, (B) after the first 
purification step, (C) after the final purification step. 
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The structure of intermediate compound (2) was verified by high-resolution 1H 
and 13C NMR spectroscopy. The peak assignments were determined from the 1-
dimensional 1H and 13C NMR spectra, coupled with 2-dimensional 1H-1H COSY and 1H-
13C HMQC NMR spectroscopy.  1H NMR data in CD3SOCD3: * 6.05 (doublet, 7 OH, J 
= 6.5 Hz); * 5.94 (doublet, 7 OH, J = 2 Hz); * 4.99 (doublet, 7 H-1, J1-2 = 3.5 Hz); * 
3.80 (doublet, 7 H-6, J6-6′ = 9.5 Hz); * 3.65 (triplet, 7 H-3, J3-2 = 9.0 Hz, J3-4 = 9.5 Hz); * 
3.59 (triplet, 7 H-5, J5-4  = 9.0 Hz, J5-6′ = 9.0 Hz); ); * 3.44 (triplet, 7 H-6′, J6′-5  = 9.0 Hz, 
J6′-6 = 9.5 Hz); * 3.38 (multiplet, 7 H-2); * 3.291 (triplet, 7 H-4, J4-3 = 9.5 Hz, J4-5 = 9.0 
Hz); 13C NMR data in CD3SOCD3: *102.80 (C-1); * 86.2 (C-4); * 72.85 (C-2); * 72.59 
(C-3); * 71.64 (C-5); * 10.17 (C-6).  1H - 1H COSY and 1H - 13C HMQC NMR spectra in 
Figures 5 and 6 show the proton and carbon contours that were used for assignment of 
the signals. 
High resolution MALDI-TOF-MS was used to determine the molecular mass of 
intermediate compound (2). The Na+ ion-adduct portion of the mass spectrum of 
intermediate compound (2) is shown in Figure 7.  The calculated molecular mass value 
of the Na+ ion-adduct of the parent molecule, 1681.43, agrees well with the value 
obtained using MALDI-TOF-MS, 1680.89, indicating the presence of seven iodine 
atoms on intermediate compound (2).  
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Figure 5.  1H-1H COSY of intermediate compound (2) in DMSO-d6, using 500 MHz 
NMR spectrometer. 
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Figure 6.  1H-13C HMQC of intermediate compound (2) in DMSO-d6, using a 500 MHz 
NMR spectrometer. 
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Figure 7.  The Na+ ion-adduct portion of the high resolution MALDI-TOF-MS spectrum 
of intermediate compound (2). 
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2.2.2 Heptakis(6-deoxy-6-morpholino)-$-cyclodextrin 
Intermediate compound (2) was converted to heptakis(6-deoxy-6-morpholino)-$-
cyclodextrin, intermediate compound (3), having all the iodine atoms at the primary 
positions substituted with morpholine by reacting (2) in excess morpholine at 65 °C for 
18 hours. Since the pKa of a substituted tertiary amine moiety is typically lower than 
that of the secondary amine precursor [92], it was expected that free morpholine will 
deprotonate the tertiary amine $-CD to give intermediate compound (3).  Intermediate 
compound (3) is protonoted in a buffer with a pH lower than its pKa, and become 
charged, allowing for the monitoring of the progress of the reaction and the 
determination of the purity of intermediate compound (3) by indirect UV-detection CE.  
CE was performed, using a 20 mM acetic acid buffer titrated to pH 4.55 with imidazole 
as the BE, with the detector placed at the cathode.  The reaction was stopped when the 
normalized target peak area relative to the other minor components was over 98%.  The 
workup involved the evaporation of the reaction solvent under reduced pressure at 50 
°C, leaving a brown solid material, which was repeatedly digested with ethanol to obtain 
intermediate compound (3) in its pure form. The isomeric purity of the final product was 
determined to be greater than 98% as shown in Figure 8. 
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Figure 8.  Indirect UV-detection electropherogram of intermediate compound (3).  
Conditions: 25 µm I. D. fused silica capillary, 20 mM acetic acid / imidazole BE, pH = 
4.6, (+) to (-) polarity.  
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The structure of intermediate compound (3) was verified by high-resolution 1H 
and 13C NMR spectroscopy.  Two solvents were used to obtain the 1H NMR spectra of 
intermediate compound (3).  Originally, the first 1H NMR spectrum obtained in CDCl3 
showed that protons at C-2, C-3 and C-5 of the CD, and the protons on the morpholinio 
substituent could not be resolved.  Even though the CDCl3 solvent allowed for the 
observation and identification of the hydroxy protons at C-2 and C-3, there was a need to 
resolve the other proton signals, and check for the presence of impurities.  Because of 
the poor resolution of the proton signals with CDCl3, a second 1H NMR spectrum was 
obtained in deuterated pyridine.  Figures 9 and 10 show the two 1H NMR spectra of 
intermediate compound (3) obtained in CDCl3 and deuterated pyridine, respectively.  
Comparison of the two spectra also facilitated the characterization of intermediate 
compound (3).  The peak assignments were determined from the 1-dimensional 1H and 
13C NMR spectra, coupled with 2-dimensional 1H-1H COSY and 1H-13C HMQC NMR 
spectroscopy.  1H NMR data in CDCl3: * 6.83 (singlet, 7 OH); * 5.29 (singlet, 7 OH); * 
5.00 (doublet, 7 H-1, J1-2 = 3.5 Hz); * 3.99 (triplet, 7 H-3, J3-4  = 9.0 Hz, J3-2  = 9.0 Hz); * 
3.74 – 3.60 (multiplet, 49 H-2, H-4, H-5, and morpholine); * 2.75 (doublet of doublets 7 
H-6, J6-6’ = 4.2 Hz, J6-5 = 3.7 Hz); * 2.64 (multiplet, 14 (CH2C); * 2.51 – 2.38 (multiplet, 
7 (CH2C), 7 H-6). 1H NMR data in pyridine-d5: * 4.44 (doublet, 7 H-1, J1-2 = 3.5 Hz); * 
3.48 (triplet, 7 H-3, J3-2  = 9.5 Hz, J3-4  = 9.5 Hz); * 3.26 (doublet of doublets, 7 H-5, J5-4  
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= 6.0 Hz, J5-6 = 6.0 Hz); * 3.04 – 2.98 (multiplet 7 H-2 and 7 H-4); * 2.64 ( broad singlet, 
7 (CH2C); * 2.07 (doublet of doublets, 7 H-6, J6-5 = 6.0 Hz, J6-6′ = 13.0 Hz); * 1.77 
(doublet, 7 H-6′, J6′-6 = 13.0 Hz); * 1.68 (broad singlet, 7 (CH2C)); *1.55 (broad singlet, 
7 (CH2C)); 13C NMR data in Pyridine-d5: 104.0 (C-1); * 85.1 (C-2); * 75.1 (C-3); * 74.5 
(C-4); * 72.0 (C-5); * 67.7 (CH2C); * 59.2 (C-6); * 55.7 (CH2C).  1H - 1H COSY and 1H 
- 13C HMQC NMR spectra in Figures 11 and 12 show only those proton and carbon 
contours that were used for signal assignment. 
High resolution MALDI-TOF-MS was used to determine the molecular mass of 
intermediate (3). A portion of the mass spectrum (the H+, Na+ and K+ ion-adduct 
portion) of intermediate (3) is shown in Figure 13.  The calculated molecular mass 
values of the H+, Na+ and K+ ion-adducts of the parent molecule, 1618.78, 1640.76, and 
1656.74 agree well with the values obtained using MALDI-TOF-MS, 1618.63, 1640.62 
and 1656.57 respectively, indicating the presence of seven morpholine moieties in 
intermediate compound (3). 
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Figure 9.  1H NMR spectrum of intermediate compound (3) in CDCl3, using a 500 MHz 
NMR spectrometer. 
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Figure 10.  1H NMR spectrum of intermediate compound (3) in pyridine-d5, using a 500 
MHz NMR spectrometer. 
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Figure 11.  1H-1H COSY of intermediate compound (3) in pyridine-d5, using a 500 MHz 
NMR spectrometer. 
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Figure 12.  1H-13C HMQC of (3) in pyridine-d5, using a 500 MHz NMR spectrometer. 
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Figure 13.  Part of the high resolution MALDI-TOF-MS spectrum of intermediate 
compound (3). 
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2.2.3 Heptakis(6-deoxy-6-morpholinio)-$-cyclodextrin Iodide 
The most common procedure for the quaternarization of tertiary amines involves 
the addition of excess methyl iodide to the amine in DMF.  Therefore, methyl iodide was 
added to a solution of intermediate (3) in 1-methyl-2-pyrrolidinone (NMP), and refluxed 
at 45 °C for 24 hours to give heptakis(6-deoxy-6-morpholinio)- $-cyclodextrin iodide, 
intermediate compound (4).  NMP was used instead of DMF because NMP is a dipolar 
aprotic solvent that has been shown to be superior to DMF for nucleophilic substitution, 
and it is more stable than DMF under acidic or basic conditions [92].  Methyl iodide had 
to be added to the reaction solution in the presence of Na2CO3 to release of the free 
amines from their hydrohalide salts to permit complete alkylation.  The progress the 
reaction was monitored in D2O by 1H NMR.  The workup involved the evaporation of 
the reaction solvent under reduced pressure at a temperature of 60 °C, which produced a 
brownish paste that dissolved readily in water.  The off-white solid, intermediate (4), 
was precipitated from the aqueous solution with acetone, and subsequently recrystallized 
from a methanol-ethanol mixture to produce pure intermediate compound (4).  The 
isomeric purity of the final product was determined to be greater than 98% by indirect 
UV-detection CE.  Figure 14 depicts the electropherogram of intermediate compound (4) 
obtained by using 20 mM formic acid, titrated to pH 3.4 with aniline as BE. 
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Figure 14.  Indirect UV-detection electropherogram of intermediate (4).  Purity > 97%.  
Conditions: 20 mM formic acid / aniline, pH = 3.4, (+) to (-) polarity, Lt/Ld = 26.4 / 19.6 
cm, 18 kV, 214 nm, T = 22 °C. 
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The structure of intermediate compound (4) was verified by high-resolution 1H 
and 13C NMR spectroscopy.  The initial 1H NMR spectrum that was acquired at 22 °C 
showed unusually broad line widths for the cyclodextrin proton signals as well as the 
proton signals of the morpholinio substituents, suggesting the presence of impurities in 
the intermediate product.   To investigate this possibility, 1H NMR of intermediate 
compound (4) was acquired at different temperatures in the 22 °C to 70 °C range.  
Figure 15 depicts the 1H NMR spectra of intermediate compound (4) at 22 °C and 60 °C 
with decrease in the peak line width for the proton signals at higher temperature, 
indicating that intermediate compound (4) exists in different conformations that 
interconvert rapidly as the viscosity of the sample solution is decreased with an increase 
in temperature.  The peak assignments were determined from the 1-dimensional 1H and 
13C NMR spectra, coupled with 2-dimensional 1H-1H COSY and 1H-13C HMQC NMR 
spectroscopy.  1H NMR data in D2O. 60 °C: * 5.59 (doublet, 7 H-1, J1-2 = 3.0 Hz); * 5.03 
(triplet, 7 H-5, J5-4 = 8.0 Hz, J5-6 = 8.0 Hz); * 4.42 (triplet, 7 H-3, J3-2 = 8.0 Hz, J3-4 = 8.0 
Hz); * 4.40 – 4.25 (multiplet, 7 H-6, 14 (CH2)); * 4.07 (triplet, 7 H-4, J4-3 = 8.0 Hz, J4-5 
= 8.0 Hz); * 4.02 (doublet of doublets, 7H-2, J2-1 = 3.0 Hz, J2-3 = 8.0 Hz); *  4.00 – 3.94 
( multiplet, 7 (CH2)); * 3.93 – 3.84 (multiplet, 7 H-6, 7 (CH2)); * 3.66 (singlet, 7 (CH3)).  
13C NMR data in D2O: 98.58 (C-1); * 79.0 (C-4); * 71.1 (C-2); * 70.7 (C-3); * 68.4 (C-
5); * 65.7 (C-6); * 61.3 (CH2); * 60.6 (CH2); * 48.0 (CH3).  1H - 1H COSY and 1H - 13C 
HMQC NMR spectra in Figures 16 and 17 show only those proton and carbon contours 
that were used for the assignment of the signals. 
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High resolution ESI-TOF-MS was used to determine the molecular mass of 
intermediate (4). Figure 18 shows a portion of the mass spectrum of the (M+I-) ion-
adducts of intermediate compound (4).  The calculated m/z values agree well with the 
measured ones indicating the existence of the desired product. 
 
2.2.4 Heptakis(6-deoxy-6-morpholinio)-$-cyclomaltoheptaose Chloride (HMBCD) 
 Next, the iodide counter ion of intermediate compound (4) was exchanged with 
chloride, using a strong anion exchanger.  Heptakis(6-deoxy-6-morpholinio)-$-
cyclodextrin iodide was dissolved in a minimum volume of water, and applied to a bed 
of strong anion exchanger (Amberlite IRA-400, OH form), and eluted with water.  The 
collected effluent was then titrated with HCl to a neutral pH.  Evaporation of the solvent 
provided the pure final product as off-white crystals. 
High resolution ESI-TOF-MS was used to determine the molecular mass of the 
final product. Figure 19 shows a portion of the mass spectrum of the (M+Cl-) of the final 
product), HMBCD.  The calculated m/z values agree well with the measured ones 
confirming that the desired final material, HMBCD, was synthesized, and exists in the 
chloride form. 
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Figure 15.  1H NMR spectra of intermediate compound (4) in D2O, using a 500 MHz 
NMR spectrometer.  (A) Temperature = 22 °C, (B) Temperature = 60 °C. 
 
 
 
 
 
 
 
ppm3.63.84.04.24.44.64.85.05.25.45.6
7.00
7.00
7.00
35.00
7.00
21.00
21.00
21.00
1
5 3 6A 4
2
6B
CH3
m1
m2
ppm3.03.23.43.63.84.04.24.44.64.85.05.25.45.6
A 
B 
 42
 
 
 
 
 
 
 
 
 
 
Figure 16.  1H-1HCOSY of intermediate compound (4) in D2O using a 500 MHz NMR 
spectrometer. 
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Figure 17.  1H-13C HMQC of intermediate compound (4) in D2O, using a 500 MHz 
NMR spectrometer. 
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Figure 18.  Portions of the high resolution ESI-TOF-MS spectrum of intermediate 
compound (4) for 3, 4, and 5 charge states.  Measured vales are in agreement with the 
calculated values. 
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Figure 19.  Portions of the high resolution ESI-TOF-MS spectrum of HMBCD, after ion 
exchange, for 3, 4, and 5 charge states.  Measured values are in agreement with the 
calculated values.   
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2.3 Synthesis and Characterization of PEMEDA-BCD 
Mono-quaternarized single-isomer cyclodextrins have been obtained only by 
having CDs that were selectively derivatized with a good leaving group in one of the 
glucose units of the CD, and having insignificant amounts of multiply substituted 
isomers at the other primary or secondary hydroxy group positions. The synthetic 
scheme used for the preparation of mono(6-deoxy-6-N, N, N’, N’, N’-
pentamethylethylenediammonio)-cyclomaltoheptaose (PEMEDA-BCD) is shown in 
Figure 20. The details of the synthetic procedures are outlined in the Appendix. 
 
2.3.1  Synthesis of p-Toluenesulfonyl Anhydride (Ts2O) 
p-Toluenesulfonyl anhydride was prepared by adding p-toluenesulfonic acid into 
a solution of  p-toluenesulfonyl chloride in dichloromethane, and stirring for 24 hours as 
reported in the literature [93].  This was followed by filtration of the reaction mixture, 
through silica gel.  The filtrate was then concentrated to 30% of the initial volume by 
evaporation.  The pure, white crystals of Ts2O were precipitated from the solution with 
hexane, and collected by filtration. 
  The structure of Ts2O was verified by high-resolution 1H and 13C NMR 
spectroscopy.  Figure 21 shows the 1H NMR spectrum. 1H NMR data in CDCl3 : * 7.95 
(doublet, 4 CH, J1-2 = 8.7 Hz); * 7.43 (doublet, 4 CH, J2-1 = 8.7 Hz); * 2.52 (singlet, 6 
CH3);. 13C NMR data in CDCl3: 130.2 (C-1); * 126.9 (C-2); * 21.8 (C-3).  The peak 
assignments for 1H and 13C NMR were determined from the 1-dimensional 1H and 13C 
NMR spectra. 
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High resolution ESI-TOF-MS was used to determine the molecular mass of 
Ts2O.  Figure 22 shows portions of the mass spectrum obtained for the (M-Ts), and  (M-
TsO) fragments of Ts2O.  The calculated m/z values, 171.01and 155.02 agree well with 
the measured values, 171.01 and 155.01 respectively, indicating that the desired product 
was obtained. 
 
2.3.2 Mono(6-O-tosyl)-$-cyclodextrin 
Monotosylated β-CD, intermediate compound (2), was obtained following the 
procedure published by Zhong et al. [93].  Native $-CD and freshly made tosyl 
anhydride were suspended in deionized water and stirred for two hours.  Then, a 10% 
NaOH solution was added to the reaction flask.  After 10 minutes, the reaction mixture 
was filtered using a sintered glass funnel to remove unreacted tosyl anhydride.  Then, 
ammonium chloride crystals were added to the filtrate, allowing pure intermediate 
compound (2) to precipitate from the solution, without the need for further purification.  
The precipitate was washed 2 times with deionized water and acetone, and collected by 
filtration.  The reaction progress was monitored by TLC, using aluminum-backed Silica 
60 plates and n-propanol : water : ethylactate : ammonium hydroxide; 5:3:1:1 as running 
solvent, giving an Rf = 0.68 for intermediate compound (2).  The purity of intermediate 
compound (2) was determined by an isocratic normal phase HPLC separation, using a 
4.6 mm I. D. × 250 mm Zorbax silica column and a 30 : 70,  
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Figure 20.  Synthesis scheme for mono(6-deoxy-6-N,N,N′,N′,N′-
pentamethylethylendiammonio)-β-CD (PEMEDA-BCD). 
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Figure 21.  1H NMR spectrum of p-toluenesulfonyl anhydride in CDCl3, using a 500 
MHz NMR spectrometer. 
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Figure 22. High resolution ESI-TOF-MS spectrum showing the fragment ions of p-
toluenesulfonyl anhydride. 
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ethylacetate : methanol binary mobile phase at 2.0 mL / min, at ambient temperature.  
The chromatogram of intermediate (2), after washing with deionized water and acetone, 
is shown in Figure 23.  An isomeric purity > 98% was obtained for intermediate 
compound (2).  
The structure of intermediate compound (2) was verified by high-resolution 1H 
and 13C NMR spectroscopy. The peak assignments were determined from the 1-
dimensional 1H and 13C NMR spectra, coupled with 2-dimensional 1H-1H COSY and 1H-
13C HMQC NMR spectroscopy.  1H NMR data in CD3OSCD3 : * 7.75 (doublet, 2 
CHmetaTs, J = 8.5 Hz); * 7.42 (doublet, 2 CHorthoTs, J = 8.5 Hz); * 5.81 (doublet, 1 OH of 
the monosubstituted glucopyranose unit, J = 6.5 Hz); * 5.79 – 5.61 (multiplet, 12 OH); * 
4.89 – 4.73 (multiplet, 7 H-1); * 4.52 – 4.12 (multiplet, 7 OH); * 3.72 – 3.19, (multiplet, 
42 H); * 2.42, (singlet, 3 (CH3)).  13C NMR data in CD3OCD3: * 145.4 (CTs); * 137.5 
(CTs); * 128.0 (CTs); * 125.4 (CTs); * 102.3 – 101.3 (m, C-1); * 81.5 –80.8 (m); * 73.1 – 
72.0  (m); * 69.7; * 68.9; * 59.9 – 59.3 (m); * 21.2 (CH3Ts).  1H - 1H COSY and 1H - 13C 
HMQC NMR spectra in Figures 24 and 25 show only those proton and carbon contours 
that are related to the glucose unit. 
High resolution MALDI-TOF-MS was used to determine the molecular mass of 
intermediate compound (2). A portion of the MALDI-TOF-MS spectrum (the Na+ and 
K+ ion-adduct portions) of intermediate compound (2) is shown in Figure 26.  The 
calculated m/z value of the Na+ ion-adduct of the parent molecule, 1311.37 and agrees 
well with the value obtained using MALDI-TOF-MS, 1327.34, indicating the presence 
of the $-cyclodextrin bearing a single tosyl group. 
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Figure 23.  Chromatogram of intermediate compound (2).  Purity > 98%.  Conditions: 
EtOAc : MeOH = 70 : 30, 2.0 mL/min, 5 µm silica column.  
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Figure 24.  1H-1H COSY of intermediate compound (2) in DMSO-d6, using a 500 MHz 
NMR spectrometer. 
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Figure 25.  1H-13C HMQC of intermediate compound (2) in DMSO-d6, using a 500 MHz 
NMR spectrometer. 
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Figure 26.  A portion of  MALDI-TOF-MS spectrum of intermediate compound (2). 
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2.3.3 Mono(6-deoxy-6-pyridinium)-$-cyclodextrin (CDP) 
Then, the mono(6-O-tosyl)-$-CD, intermediate (2), was used to synthesize a 
mono-quaternarized $-CD according to a modified procedure described in [94]. The 
modification involved adding dry pyridine (both reagent and solvent) to a reaction flask 
purged with nitrogen, followed by addition of intermediate compound (2).  The flask 
was heated to 70 °C and stirred under a nitrogen blanket for 48 hours. Progress of the 
reaction was followed by direct UV-detection CE, using a 50 mM phosphoric acid buffer 
titrated with lithium hydroxide to pH 2.13 as BE, with the detector placed at the cathode.  
Next, excess pyridine was evaporated under reduced pressure, the residue was dissolved 
in deionized water, and the undissolved solids were filtered off.  After concentration of 
the aqueous solution to about 60% of its original volume by evaporation, solid material 
was precipitated from the solution by slow addition of acetone.  The precipitate was then 
collected by filtration, dissolved in a minimum volume of water, and reprecipitated with 
acetone.  The procedure was repeated 3 times, the product was dried in a vacuum oven at 
room temperature, and analyzed by CE.  The isomeric purity of the final product, 
mono(6-deoxy-6-pyridinium)-$-cyclodextrin (CDP), was determined by CE to be 
greater than 98% as shown in Figure 27. 
The structure of CDP was verified by high-resolution 1H and 13C NMR  
spectroscopy. The peak assignments were determined from the 1-dimensional 1H and 
13C NMR spectra, coupled with 2-dimensional 1H-1H COSY and 1H-13C HMQC NMR 
spectroscopy.  1H NMR data in D2O: * 8.82 (doublet, 2 H, pyridine, J = 6.0 Hz); * 8.51 
(triplet, 1 H, pyridine, J = 8.0 Hz,); * 8.00 (doublet of doublets, 2 H, pyridine, J = 6.0 
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Hz, J = 8.0 Hz); * 7.53 (doublet, 2 H, tosylate, J  = 8.0 Hz); * 7.07 (doublet, 2 H, 
tosylate, J  = 8.0 Hz); * 5.06 (doublet, 1 H-1' of the monosubstituted glucopyranose unit, 
J = 7.5 Hz); * 4.99 (doublet, 1 H-1, J = 3.5); * 4.90 – 4.84 (multiplet, 4 H-1); * 4.79 
(doublet, 1 H-1, J = 3.5); * 4.12 (triplet, 1 H, J = 9.0); * 3.96 – 3.93 (multiplet 37 H); * 
3.26 (triplet, 1 H, J = 9.0); * 2.73 (doublet, 1 H, J = 10); * 2.35, 2.33 (doublet of 
doublets, 1 H, J = 4.0); * 1.96 (singlet, CH3, tosylate).  13C NMR data in D2O: * 146.1 
(Cpyr); * 145.5 (Cpyr); * 145.4 (CTs); * 137.5 (CTs); * 128.0 (CTs); * 127.9 (CTs); * 125.4 
(CTs); * 100.9 – 102.3 (multiplet, C-1); * 83.6; * 82.9; * 81.4; * 80.6; * 73.4; * 73.0; * 
72.3; * 72.1; * 71.9; * 71.3; * 70.2; * 61.6; * 60.8; * 59.8; * 58.7; * 20.7 (CH3Ts).  1H - 
1H COSY NMR spectrum in Figure 28 shows all the proton contours that are related to 
the molecule. 
The molecular mass of CDP was determined by high resolution MALDI-TOF-
MS.  A portion of the mass spectrum of CDP is shown in Figure 29.  The measured m/z 
value of 1196.53 agrees well with the calculated value, 1196.41, for the monoisotopic 
(M) parent ion of CDP. 
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Figure 27.  UV-detection electropherogram of CDP.  Purity > 98%.  Conditions: 50 mM 
phosphoric acid / LiOH, pH = 2.13, (+) to (-) polarity, Lt/Ld = 26.4 / 19.6 cm, 18 kV, 
214 nm, T = 20 °C. 
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Figure 28.  1H-1H COSY of CDP in D2O, using a 500 MHz NMR spectrometer. 
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Figure 29.  A portion of high resolution MALDI-TOF-MS spectrum of CDP.  The 
measured m/z value of 1196.53 is in agreement with the value calculated for the 
monoisotopic parent ion. 
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2.3.4 Mono(6-deoxy-6-N, N, N’, N’, N’-pentamethylethylenediamino)- $-
cyclodextrin 
Mono(6-deoxy-6-N,N,N’,N’,N’-pentamethylethylenediamino)-$-cyclodextrin, 
intermediate (3), was synthesized based on the procedure used for the synthesis of CDP.  
Dry intermediate (2) was added to N,N’, N’-trimethylethylenediamine in the reaction 
flask, heated to 60 °C under a blanket of dry nitrogen for 18 hours. Progress of the 
reaction was monitored by two complementary methods; (i) indirect UV-detection CE, 
using a 20 mM acetic acid solution titrated to pH 4.55 with 10 mM imidazole as the BE, 
and (ii) direct UV-detection CE, using 25 mM phosphoric acid titrated to pH 2.55 with 
lithium hydroxide as the BE to follow the disappearance of mono-tosylated $-CD.  The 
second method was based on the results of previous experiments, which showed that 
unreacted neutral tosyl β-CD, in low pH phosphoric acid/LiOH buffer, complex with 
dihydrogen phosphate and became negatively charged.  After quenching, the reaction 
mixture was evaporated to dryness under reduced pressure.  The resulting solid was 
dissolved in a minimum volume of water, and precipitated by slow addition of ethanol. 
Further purification was performed by repeating the procedure 3 times.  The product was 
dried in a vacuum oven at room temperature, and analyzed by CE.  Figure 30 depicts the 
aqueous indirect UV-detection electropherogram of intermediate compound (3).  The 
final isomeric purity of intermediate compound (3) is greater than 98%.  
The structure of intermediate compound (3) was verified by high-resolution 1H 
and 13C NMR spectroscopy. The peak assignments were determined from the 1-
dimensional 1H and 13C NMR spectra, coupled with 2-dimensional 1H-1H COSY and 1H-
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13C HMQC NMR spectroscopy.  1H NMR data in CD3SOCD3: * 5.96 (doublet, 1 (OH), 
J = 6.5 Hz); * 5.81 – 5.65 (multiplet, 14 (OH)); * 4.87, 4.84, 4.80 (three sets of doublets, 
7 H-1, J = 5 Hz); * 4.60 – 4.39 (broad singlet, 5 (OH)); * 3.76 – 3.52 (multiplet, 26 H); 
* 3.43 – 3.25 (13 H); *  3.18 (triplet, 1 H, J = 10 Hz); * 2.71(doublet, 1 H, J = 15 Hz); *  
2.47 (quartet, 2 H, J = 5 Hz); * 2.41 – 2.35 (multiplet, 1 H); * 2.33 – 2.24 (multiplet, 1 
H); *  2.17 ( singlet, (CH3)N); * 2.09 (singlet, 2(CH3)N); 13C NMR data in CD3SOCD3:  
102.83 – 102.24 (multiplet, C-1); * 45.98 ( (CH3)2N); * 43.90 ((CH3)N); 1H - 1H COSY 
and 1H - 13C HETCOR NMR spectra in Figures 31 and 32 show only those proton and 
carbon contours that are related to the glucose unit. 
High resolution MALDI-TOF-MS was used to determine the molecular mass of 
intermediate (3). A portion of the mass spectrum (the Na+ and K+ ion-adduct portion) of 
intermediate (3) is shown in Figure 33.  The calculated molecular mass values for the 
H+, Na+ and K+ ion-adducts of the parent molecule, 1219.48 and 1241.47, 1257.44, agree 
well with the values obtained using MALDI-TOF-MS, 1219.29 and 1241.47, 1257.27, 
indicating the existence of the target material, mono(6-deoxy-N,N,N’,N’,N’-6-
pentamethylethylenediamine)-$-cyclodextrin. 
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Figure 30.  Indirect UV-detection electropherogram of intermediate compound (3).  
Purity > 98%.  Conditions: 20 mM acetic acid / imidazole, pH = 4.6, (+) to (-) polarity, 
Lt/Ld = 26.4 / 19.6 cm, 18 kV, 214 nm, T = 20 °C. 
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Figure 31.  1H-1H COSY of intermediate compound (3) in DMSO-d6, using a 500 MHz 
NMR spectrometer. 
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Figure 32.  1H-13C HMQC of intermediate compound (3) in DMSO-d6, using a 500 MHz 
NMR spectrometer. 
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Figure 33.  A portion of the high resolution MALDI-TOF-MS spectrum of intermediate 
(3).  Measured m/z values are in agreement with those calculated for the monoisotopic 
proton, sodium, and potassium adducts. 
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2.3.5 Mono(6-deoxy-6-N,N,N’,N’,N’-pentamethylethylenediammonio)-β-
cyclodextrin Iodide 
Intermediate compound (4) was synthesized according to the common synthetic 
method for preparation of quaternary ammonium derivatives.  Dry DMF was added into 
a three-neck reaction flask, and purged with dry nitrogen.  Then, intermediate (3) was 
dissolved in DMF, followed by slow addition of methyl iodide.   The flask was stirred 
under a blanket of nitrogen, heated to 40 °C, and refluxed.  Progress of the reaction was 
monitored by indirect UV-detection CE, using a 20 mM acetic acid solution, titrated to 
pH 4.55 with 10 mM imidazole as the BE.  The workup involved evaporation of the 
reaction solvent under reduced pressure, dissolving the residue in a minimum volume of 
deionized water, and precipitation with acetone.  The solids were collected by suction 
filtration.  This procedure was repeated three times to obtain pure intermediate (4), 
having iodide as the counter ion. CE analysis of the final product, after drying in a 
vacuum oven at room temperature, showed an isomeric purity of  > 98% for the target, 
Figure 34. 
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Figure 34.  Indirect UV-detection electropherogram of intermediate compound (4).  
Purity > 98%.  Conditions: 20 mM acetic acid / imidazole, pH = 4.6, (+) to (-) polarity, 
Lt/Ld = 26.4 / 19.6 cm, 18 kV, 214 nm, T = 20 °C. 
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Figure 35.  1H NMR spectrum of intermediate compound (4) in D2O, obtained by using 
500 MHz NMR spectrometer. 
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The structure of intermediate compound (4) was verified by high-resolution 1H 
and 13C NMR spectroscopy. The peak assignments were determined from the 1-
dimensional 1H and 13C NMR spectra, coupled with 2-dimensional 1H-1H COSY and 1H-
13C HMQC NMR spectroscopy.  Figure 35 shows the full 1H NMR spectrum of 
intermediate compound (4).  1H NMR data in D2O: * 5.05 (doublet, 1 H-1, J = 5.0 Hz); * 
4.98 (doublet, 1 H-1, J = 5.0 Hz); * 4.96 (triplet, 2 H-1, J = 3.5 Hz, J = 3.5 Hz); * 4.93 
(doublet, 1H-1, J = 4.0 Hz): * 4.91 (doublet, 1 H-1, J = 4.0 Hz); * 4.89 (doublet, 1 H-1, J 
= 4.0 Hz); * 4.46 (triplet, 1 H-5, J = 10.0 Hz, J = 10.0 Hz); * 4.01 – 3.39 (multiplet, 44 
H); * 3.33 (triplet, 1 H-4, J = 10 Hz, J = 10.0 Hz); * 3.20, 3.19 (two sets of (CH3)N); * 
3.13 (singlet, 3(CH3)N); 13C NMR data in D2O: * 102.57 – 101.67 (C-1(B-G)); * 100.67 
(C-1A); * 81.93 (C-4A); * 67.47 (C-5A); * 54.01 3(CH3)N; * 53.00, 52.64 2(CH3)N.  1H - 
1H COSY and 1H - 13C HMQC NMR spectra in Figures 36 and 37 show only those 
proton and carbon contours that are related to the glucose unit. 
High resolution ESI-TOF-MS was used to determine the molecular mass of 
intermediate (4). Figure 38 shows a portion of the mass spectrum of the (M-2I-)/z ion of 
intermediate compound (4).  The calculated (M-2I-)/z value, 624.25, agrees well with the 
measured one, 624.26, indicating that the desired product was prepared. 
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Figure 36.  1H-1H COSY of intermediate compound (4) in D2O, using a 500 MHz NMR 
spectrometer. 
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Figure 37.  1H-13C HMQC of intermediate compound (4) in D2O, obtained by using a 
500 MHz NMR spectrometer. 
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Figure 38.  A portion of the high resolution ESI-TOF-MS spectrum of intermediate 
compound (4).  
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2.3.6 Mono(6-deoxy-6-N,N,N’,N’,N’-pentamethylethylenediammonio)-
cyclomaltoheptaose Chloride (PEMEDA-BCD) 
Finally, the iodide counter ion of intermediate (4) was exchanged with chloride, 
using a strong anion exchanger. Mono(6-deoxy N,N,N’,N’,N’-6-
pentamethylethylenediammonio)-cyclomaltoheptaose iodide was dissolved in a 
minimum volume of water, and applied to a bed of strong anion exchanger (Amberlite 
IRA-400, OH form), and eluted with water.  The collected, basic effluent was then 
titrated with HCl to a neutral pH.  Evaporation of the solvent provided the pure final 
product as off-white crystals.  The exchange of iodide by chloride was confirmed by 
direct UV-detection CE analysis of the final product, using a 25 mM phosphoric acid 
solution titrated to pH 2.55 with lithium hydroxide as the BE, and the detector placed at 
the anode.   
High resolution MALDI-TOF-MS was used to determine the molecular mass of 
PEMEDA-BCD. Figure 39 shows a portion of the mass spectrum for PEMEDA-BCD 
after exchange of the counter ion.  The calculated m/z value agrees well with the 
measured value confirming that the desired material, PEMEDA-BCD, was successfully 
made. 
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Figure 39.  A portion of the high resolution MALDI-TOF-MS spectrum of PEMEDA-
BCD.   
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2.4 Synthesis of Anionic Analytes 
Ten anionic racemic analytes, 1-phenyl-1-O-sulfo-propane, 2-phenyl-1-O-sulfo-
propane, 1-phenyl-2-O-sulfo-propane, 1-phenyl-1-O-sulfo-butane, 2-phenyl-1-O-sulfo-
butane, 1-phenyl-2-O-sulfo-propane, 1-phenyl-1-O-sulfo-pentane, 1-phenyl-2-O-sulfo-
pentane, 1-phenyl-1,2-di-O-sulfo-ethane, trans-2-phenyl-1-O-sulfo-cyclohexane, were 
synthesized by sulfating the corresponding alcohols with sulfur trioxide pyridine 
complex (SO3-py) in DMF. All the sulfated analytes were prepared by the same 
procedure. Progress of the reaction was monitored by direct UV-detection CE, using a 
BE containing 20 mM boric acid titrated to pH 9.0 with LiOH.  The workup procedure 
involved the evaporation of the excess solvent until a paste was obtained.  The paste was 
dissolved in a small volume of deionized water, and titrated to pH 7 with a sodium 
hydroxide solution.  The solution that resulted was added to an equal volume of acetone, 
excess sodium sulfate precipitated, and was filtered off.  Then, the filtrate was 
evaporated to dryness at 40 °C to obtain the sodium salts of the sulfated analytes. Figure 
40 depicts the CE separation of a representative of the anionic analytes. 
High resolution ESI-TOF-MS was used to determine the molecular mass of the 
anionic analytes. Figures 41 to 45 show portions of the mass spectra of the (M-Na+) ion 
of some of the anionic analytes.  The calculated m/z values agree well with the measured 
ones confirming that the desired anionic analytes were successfully synthesized. 
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Figure 40.  Direct UV-detection electropherogram of 1-phenyl-2-O-sulfo-propane.  
Purity > 99%.  Conditions: 25 µm I. D. fused silica capillary, 20 mM boric acid  / LiOH 
pH = 9.0, 18 kV (+) to (-) polarity, 214 nm. 
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Figure 41.  A portion of the high resolution ESI-TOF-MS spectrum of 1-phenyl-2-O-
sulfo-propane.  The measured m/z value of 215.01 agrees with 215.04 calculated for the 
monoisotopic ion. 
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Figure 42.  A portion of the high resolution ESI-TOF-MS spectrum of 1-phenyl-2-O-
sulfo-butane.  The measured m/z value of 229.10 agrees with the 229.05 value calculated 
for the monoisotopic ion. 
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Figure 43.  A portion of the high resolution ESI-TOF-MS spectrum of 1-phenyl-2-O-
sulfo-pentane.  The measured m/z value of 243.04 agrees with the 243.07 value 
calculated for the monoisotopic ion. 
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Figure 44.  A portion of the high resolution ESI-TOF-MS spectrum of 1-phenyl-1,2-di-
O-sulfo-ethane monosodium salt .  The measured m/z value of 319.02 agrees with the 
318.96 value calculated for the monoisotopic monoanion. 
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Figure 45.  A portion of the high resolution ESI-TOF-MS spectrum of trans-2-phenyl-1-
O-sulfo-cyclohexane.  The measured m/z value of 255.05 agrees with the 255.07 value 
calculated for the monoisotopic ion.   
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2.5 Summary of Synthesis Methods 
The chloride salts of heptakis(6-deoxy-6-morpholinio)-cyclomaltoheptaose and 
the tosylate salts of mono(6-deoxy-6-N,N,N’,N’,N’-pentamethylethylenediammonio)-
cyclomaltoheptaose, and mono(6-deoxy-6-pyridinium)-cyclomaltoheptaose have been 
synthesized at a large scale.  The key to successful synthesis of these products lies in the 
selectivity of the first synthetic step of each scheme.  Although these procedures have 
been reported in the literature, the modifications reported here have permitted large 
quantities to be made at high purity, which facilitated the synthesis of the final products.  
Subsequent procedures for the final products have not been previously reported in the 
literature.  The choice of reagents for the synthesis was very crucial.  For example, 
complete amination of the CD on the primary face could only be done with morpholine.  
Ten anionic analytes have also been synthesized using known procedures.  These 
analytes are permanently charged, and will serve as probes for the evaluation of the 
newly synthesized cationic chiral resolving agents. 
The purity of each intermediate and the final products was determined by HPLC, 
direct UV-detection and indirect UV-detection CE.  The structural identity of each CD 
derivative was confirmed by 1D 1H NMR and 13C NMR, 2D NMR and MALDI-TOF-
MS.  HMBCD and PEMEDA-BCD are single-isomer, cationic CDs with purities greater 
than 98%, and have been thoroughly characterized for use as chiral resolving agents in 
capillary electrophoresis. 
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CHAPTER III 
 
SEPARATION OF ENANTIOMERS 
 
Charged cyclodextrins derivatives (CCDs) have frequently been used as chiral 
selectors in CE [95].  Chiral recognition with cyclodexrtrin (CD) analogues typically 
results from an inclusion of a hydrophobic portion of the analyte into the CD cavity as 
well as interactions with the hydroxy groups at the rims of the cavity [96].  In addition to 
these intermolecular interactions, CCDs also take advantage of ion-pairing interactions 
to stabilize the inclusion complex.  HMBCD and PEMEDA-BCD are positively charged  
$-CDs differing in the number of charges and substituents on the CD skeleton.  
According to the CHARM model [49], when strong electrolyte resolving agents, such as 
HMBCD and PEMEDA-BCD are used for the CE resolution of enantiomers, only two 
stock BEs, one with a low pH and another with a high pH are required to find the 
conditions that lead to the highest enantioselectivities. Previous work done with single-
isomer sulfated CDs shows that good resolution and favorable β values are obtained in 
low pH BEs where most of the weak base analytes are protonated. Although HMBCD 
and PEMEDA-BCD are designed for the separation of anionic analytes, separation 
studies with nonionic and cationic analytes were also performed in this work. 
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3.1 Separations with HMBCD 
Two groups of analytes were used for the study of enantiomer separations with 
HMBCD; the new, sulfated, permanently charged anionic analytes, and a set of weak 
acid analytes, both in high pH BEs.  In addition to hydrophobic, hydrogen bonding, and 
weak van der Waals interactions, there are also electrostatic interactions which stabilize 
the complexes formed by the negatively charged anions and the multiply, positively 
charged, highly water soluble heptakis(6-deoxy-6-morpholinio)-cyclomaltoheptaose 
chloride (HMBCD). 
 
3.1.1 Materials 
All the analytes were obtained from Sigma (St. Louis, MO), except for the 
sulfated analytes, which were synthesized and characterized in our laboratory as 
described in the previous chapter.  Methanesulfonic acid, ethanolamine, and 
dimethylsulfoxide were purchased from Aldrich Chemical Company (Milwaukee, WI). 
HMBCD was synthesized and analytically characterized in our laboratory as described 
in Chapter II. Deionized water from a Milli-Q unit (Millipore, Milford, MA) was used to 
prepare all the solutions that were used in the experiments. The high pH stock buffer was 
prepared by titration of a 25 mM ethanolamine solution to pH 9.3 with methanesulfonic 
acid. The chiral resolving agent-containing BEs were prepared immediately prior to use 
by weighing out the required amounts of the chloride salt of HMBCD into 25 ml 
volumetric flasks and bringing the volumes to mark with the stock BE solution.   
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3.1.2 CE Conditions 
 All enantiomer separations were performed on a P/ACE 2010 capillary 
electrophoresis instrument using a 25 µm i.d., bare fused silica capillary (Polymicro 
Technologies, Phoenix, AZ, USA) with a total length (Lt) of 26.4 cm, injector to detector 
length of 19.6 cm (Ld). A window for UV detection was prepared by removing a section 
of the polyimide coating with a flame, and then the capillary was wiped clean with a 
methanol-soaked Kimwipe. All separations were obtained at 9-18 kV applied potential, 
positive to negative or negative to positive electrode polarity, at 214 nm detection 
wavelength, and 20 oC cartridge coolant temperature. Between runs, the capillary was 
flushed with deionized water for 4 min, followed by the running buffer for 2 min. The 
analytes were either pressure injected by 2 psi nitrogen for 1 s or electrokinetically 
injected by 10 kV for 5 s. All solutions used were passed through a 0.45µm pore size 
disc filter prior to use.   
 
3.1.3 Methods 
Dimethylsulfoxide (DMSO), which has been reported to have zero effective 
mobility with charged CDs [97], was selected as the electroosmotic flow mobility 
marker for HMBCD as well.  Its suitability as mobility marker was experimentally 
verified according to the procedure reported in the literature [98]. To determine the 
suitability of DMSO as neutral marker, the capillary was filled with HMBCD-free BE 
(NHBE).  Then a band of the 50 mM HMBCD-containing BE (HBE) was injected into 
the capillary, followed by a narrow band of DMSO, and a second band of HBE which 
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sandwiched the DMSO band.  The injection sequence was repeated with NHBE 
replacing the HBE bands.  Then all bands were pressure mobilized past the detector with 
the injection end of the capillary still immersed into the NHBE vial.  This first 
mobilization allowed the recording of the first UV trace.  As soon as the second NHBE 
band moved past the detector, the pressure was released from the inlet.  Next the entire 
band train was pushed back into the first portion of the capillary, before the detector, by 
application of pressure at the outlet end of the capillary.  Next, the separation potential 
was applied for a short migration time.  If the sandwiched-DMSO in HBE complexed 
with the chiral selector, the DMSO-chiral selector complex will migrate with the 
combined bulk flow velocity and its own electrophoretic velocity.  But, the sandwiched-
DMSO in NHBE will migrate only with the bulk flow velocity.  In the last step, another 
narrow band of DMSO was injected, and all bands were pressure-mobilized past the 
detector by applying pressure to the inlet vial with the NHBE, and the second detector 
trace was then recorded.  Figure 46 shows two superimposed UV detector traces of 
DMSO during the first and second pressure mobilization steps.  The first pass shows the 
DMSO position inside the HBE band before electrophoresis. HBE band is bounded on 
both sides by NHBE bands. The second detector trace was obtained after a short 
electrophoresis step, and mobilization of all bands past the detector by nitrogen pressure. 
The position of DMSO in the HBE before and after electrophoresis, with respect to its 
position in the NHBE bands, is identical.  Because of the identical migration of DMSO 
in both the HBE and NHBE, it was concluded that DMSO does not complex with 50 
mM HMBCD (or less).  The broadening of the band and the DMSO peak in the second 
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pass is attributed to additional laminar movement caused by the mobilization pressure 
and by electrophoresis. 
Since DMSO has zero effective mobility in all HMBCD BEs used in this work, it 
can be used as neutral marker to calculate the electroosmotic flow (EOF) mobilities.  
DMSO was co-injected with each sample to obtain effective mobilities, µeff, of the 
enantiomers from the observed mobilities, µobs, as: 
eofobseff µµµ −= 11         (10) 
 
The peak resolution values Rs, were calculated using the following Equation:   
  
)(70.1
)(2
21
12
hh ww
ttRs +
−=       (11) 
         
where, subscript 2 refers to the enantiomer which has a lower effective mobility in the 
lowest HMBCD BE that was used, t1 and t2  are the observed migration times of the 
enantiomers and wh1 and wh2 are the peak widths at half heights of the respective 
enantiomer peaks.  According to the resolution equation (equation 9) [49], the higher the 
applied potential, the higher the Rs value that can be obtained.  However, Joule heating 
limits the potential that can be applied.  In order to determine the highest potentials 
where Ohm’s plots were still linear, the true electrophoretic currents were measured as a 
function of the applied potential value over the 0 to 50 mM HMBCD concentration 
range in 5 mM increments.  All effective mobility values of the analytes reported in this 
dissertation were measured in the linear region of Ohm’s plots. A  
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Figure 46.  UV-detector traces of DMSO.  Before electrophoresis, Trace 1, and after 
electrophoresis, Trace 2. 
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Figure 47.  Ohm’s plot obtained with a 50 mM HMBCD BE. 
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typical Ohm’s plot obtained with a 50 mM HMBCD BE is shown in Figure 47.  The 
viscosity values of the 0-50 mM HMBCD BEs were measured using the P/ACE 2010 
unit as a viscometer [44].  The viscosity of the solution increased by about 20 % over the 
HMBCD concentration range studied. 
 
3.1.4 Results and Discussion 
The separation behavior of a series of strong anions, weak acid, and neutral 
analytes (Figure 48) were studied with BEs that contained various concentrations of 
HMBCD. Shown in Tables 1 and 2 are the effective mobilities of the less mobile 
enantiomers, µeff, the separation selectivities, α, the measured peak resolution values, Rs, 
the corresponding dimensionless, normalized EOF mobility values, β, and the injector-
to-detector potential drop values, U, for the strong anions and weak acid analytes 
respectively. An entry of N/A indicates that a value could not be calculated due to 
overlap with either a non-comigrating system peak or the neutral marker peak. The 
applied potential decreased with increasing HMBCD concentration, ranging from 15 kV 
in the 5 mM HMBCD-containing BE to 9 kV in the 50 mM HMBCD-containing BE.  
The mobilities of the anodic EOF (µEOF) were between -(3 to 35) ×10-5 cm2/Vs over the 
5 to 50 mM HMBCD concentration range, indicating that HMBCD absorbed on the 
walls of the capillary.  Under these conditions, the free, uncomplexed, negatively 
charged analytes migrate in the direction of the EOF, while the analyte-HMBCD 
complexes migrate in the opposite direction. 
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Figure 48.  Names and structures of the strong electrolytes (all sodium salts), weak base, 
weak acid, neutral, and ampholytic analytes. 
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Figure 48.  Continued. 
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Figure 48.  Continued. 
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Figure 48.  Continued. 
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Figure 48.  Continued. 
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Figure 48.  Continued. 
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SO H
OH
OH
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Table 1.   
 
Separation data for the strong electrolyte analytes as a function of HMBCD 
concentration in pH = 9.3 BE.  µ in (10-5 cm2 V-1s-1) units. 
 
 
HMBCD (mM) 0   5    10  
U (kV)    -15    -12  
Analyte : : " $ Rs : " $ Rs 
S01 -31.7 -6.87 1.00 4.3 0.0 -5.32 1.18 5.2 <0.6 
S02 -29.6 -2.64 1.61 20.5 1.2 -1.11 4.34 22.6 0.9 
S03 -25.3 -7.73 1.25 3.8 1.4 -5.66 1.24 4.9 1.5 
S04 -25.9 -7.82 1.00 3.8 0.0 -4.49 1.00 6.1 0.0 
S05 -23.8 -9.58 1.00 3.1 0.0 -7.95 1.00 3.6 0.0 
S06 -22.5 -10.1 1.00 2.9 0.0 -8.40 1.00 3.2 0.0 
S07 -22.5 -6.39 1.00 4.7 0.0 -4.00 1.00 6.8 0.0 
S09 -53.0 -21.2 1.00 1.6 0.0 -17.5 1.00 1.7 0.0 
S10 -28.2 -8.08 1.00 3.7 0.0 -5.23 1.00 5.2 0.0 
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Table 1.  Continued 
 
 
 
HMBCD (mM) 0   20    30  
U (kV)    -9    -9  
Analyte : : " $ Rs : " $ Rs 
S01 -31.7 -3.85 1.14 5.9 1.5 -2.99 1.20 7.2 1.5 
S02 -29.6 1.25 0.59 -17 1.3 1.27 0.73 -16 1.3 
S03 -25.3 -5.17 1.13 4.3 1.3 -4.35 1.15 4.9 1.5 
S04 -25.9 -3.03 1.00 7.5 0.0 -2.26 1.00 9.7 0.0 
S05 -23.8 -6.88 1.00 3.2 0.0 -6.28 1.00 3.6 0.0 
S06 -22.5 -6.03 1.00 3.7 0.0 -5.50 1.00 4.0 0.0 
S07 -22.5 -2.07 1.00 11.1 0.0 -1.84 1.00 12 0.0 
S09 -53.0 -15.7 1.00 1.4 0.0 -13.6 1.00 1.6 0.0 
S10 -28.2 -3.47 1.00 6.5 0.0 -2.73 1.00 8.5 0.0 
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Table 1.  Continued 
 
 
HMBCD (mM) 0   50  
U (kV)    -7  
Analyte : : " $ Rs 
S01 -31.7 -1.86 1.21 8.9 1.2 
S02 -29.6 1.32 0.75 -13 1.6 
S03 -25.3 -2.35 1.24 7.1 1.7 
S04 -25.9 -1.21 1.36 14 0.9 
S05 -23.8 -3.73 1.00 4.5 0.0 
S06 -22.5 -3.72 1.00 4.4 0.0 
S07 -22.5 -1.09 1.00 15 0.0 
S09 -53.0 -11.5 1.000 1.4 0.0 
S10 -28.2 -1.3 1.32 13 1.2 
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Table 2.   
 
Separation data for weak acid analytes as a function of HMBCD concentration in pH = 
9.3 BE.  µ in (10-5 cm2 V-1s-1) units. 
 
 
HMBCD (mM) 0   5    10  
U (kV)    -15    -12  
Analyte : : " $ Rs : " $ Rs 
A01 -35.4 -18.6 1.00 1.7 0.0 -15.3 1.00 1.8 0.0 
A08 -22.7 -12.6 1.00 2.4 0.0 -10.9 1.00 2.6 0.0 
A09 -24.1 -11.9 1.00 2.7 0.0 -8.28 1.00 3.5 0.0 
A10 -21.9 -3.88 1.00 8.0 0.0 -4.43 1.00 65 0.0 
A14 -22.1 -5.15 1.00 6.2 0.0 -3.77 1.00 7.6 0.0 
A16 -27.5 -13.6 1.00 2.3 0.0 -12.3 1.00 2.3 0.0 
A17 -7.9 -2.62 1.00 8.7 0.0 -1.06 1.00 27 0.0 
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Table 2.  Continued 
 
 
HMBCD(mM) 0   20    30  
U (kV)    -9    -9  
Analyte : : " $ Rs : " $ Rs 
A01 -35.4 -14.7 1.00 1.7 0.0 -14.6 1.00 1.6 0.0 
A08 -22.7 -9.53 1.00 2.6 0.0 -9.49 1.00 2.4 0.0 
A09 -24.1 -6.95 1.00 3.5 0.0 -6.50 1.00 3.6 0.0 
A10 -21.9 2.23 1.00 -11 0.0 4.24 1.00 -5.4 0.0 
A14 -22.1 -3.75 1.00 6.6 0.0 -4.69 1.00 4.6 0.0 
A16 -27.5 -11.2 1.00 -2.2 0.0 -10.8 1.00 1.9 0.0 
A17 -7.9 1.34 1.00 -18 0.0 4.65 1.00 -47 0.0 
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3.1.4.1 Separation of the Enantiomers of Strong Electrolyte Analytes with HMBCD 
 The enantiomers of 3 of the 10 anionic compounds tested were separated within 
the concentration range studied.  The anionic effective mobilities of the enantiomers of 
these analytes decreased rapidly as the concentration of HMBCD was increased from 0 
to 10 mM, thereafter, the mobilities remained approximately constant, reaching -3×10-5 
cm2/Vs as the concentration of HMBCD was increased to 50 mM for the weakly 
complexing analytes.  For the strongly complexing anionic analytes, the effective 
anionic mobilities decreased, crossed the zero mobility line, became cationic, and 
reached 5×10-5 cm2/Vs at 50 mM as the concentration of HMBCD was increased.  
Typical effective mobility curves are shown in the top left panel of Figure 49 for four 
analytes. The mobilities reflect the increasing degree of complexation of the anionic 
analyte with increasing HMBCD concentration and the mobility-reducing effects of both 
the higher ionic strength and the higher viscosity that came with the increased 
concentration of HMBCD.  The corresponding separation selectivities for the weakly 
complexing enantiomers decreased slightly to a minimum and then increased slowly as 
the concentration of HMBCD was increased (Figure 49, top right panel), in agreement 
with the predictions of the CHARM model [49].  For the strongly binding analytes, 
separation selectivity first increased as the mobilities approached the point where they 
crossed the zero line, then became less than unity as the concentration of HMBCD was 
increased further (Figure 49, bottom right panel).  
  The size and structure of the anionic analytes can have a significant effect on the 
extent of enantiorecognition by HMBCD.  Differences in the number of carbon atoms in  
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Figure 49.  Typical effective mobilities and separation selectivities for the enantiomers 
of selected strong electrolytes with HMBCD in pH = 9.3 BEs.  Top left panel: effective 
mobilities.  Top right panel: separation selectivites for S1 and S3.  Bottom right panel 
selectivity for S2. 
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the hydrophobic chain that contains the chiral center can affect the separation selectivity 
significantly.  For example, the enantiomers of 1-phenyl-1-O-sulfo-propane (S01), 2-
phenyl-1-O-sulfo-propane (S02), 1-phenyl-2-O-sulfo-propane (S03), all having three 
carbon atoms in the alkyl chain were separated with HMBCD BEs.  However, the 
enantiomers of the different isomers of phenylsulfobutane and of phenylsulfopentane, 
with longer alkyl chains could not be resolved under the same conditions.  The position 
of the charge on the analyte relative to the aromatic ring also played a part in the chiral 
recognition process. For example, the enantiomers of phenylsulfopropane isomers, S01, 
S02 and S03 were separated in the HMBCD BEs.However, comparison of their 
separation selectivities and effective mobilities showed that the enantiomers of S02, 
having the charge and chiral center closer to the aromatic ring, complexed more 
strongly, and had higher separation selectivity values than the other two. 
 
3.1.4.2 Separation of the Enantiomers of Weak Acids with HMBCD 
 Table 2 lists the effective mobilities of the less mobile enantiomers, µ (the 
average of three measurements, typical RSD values less than 3%), the separation 
selectivities, α, the peak resolution values, Rs, the normalized EOF mobility values, β, 
and the injector-to-detector potential drop values, U (in kV), obtained in the separation 
of ten weak acid analytes studied in the concentration ranged 5 mM to 30 mM HMBCD 
at pH 9.3.  All weak acid analytes were fully dissociated in this BE.  The anionic 
effective mobilities of the enantiomers of these analytes, like those of the strong 
electrolytes, decreased rapidly between 0 and 10 mM concentration of HMBCD.  As the 
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concentration of HMBCD increased further, the effective mobilities only increased 
minimally and reached  -3×10-5 cm2/Vs at the highest concentration used (see Figure 
50).  The effective mobilities of the enantiomers of two weak acid analytes, ketoprofen 
and carprofen, decreased much faster than for the rest of the other weak acid analytes.  
They crossed the zero mobility line, and became cationic at 10 mM concentration of 
HMBCD.  This behavior is indicative of stronger interactions between the multiply 
charged HMBCD and the molecules of ketoprofen and carprofen than those of the other 
weak acid analytes.  The slow changes in the anionic effective mobilities above the 10 
mM HMBCD concentration could be attributed to the combined effects of increased 
ionic strength and viscosity that were brought about by the increased HMBCD 
concentration [44]. 
Despite the strong interactions of some of the weak acid analytes with HMBCD, 
no separation was observed for enantiomers of the weak acid analytes studied.  Even the 
enantiomers of ketoprofen and carprofen, whose effective mobilities crossed the zero 
mobility line, could no be separated over the entire concentration range of HMBCD 
studied.  It is instructive to see that the separation behavior of the anions of both the 
strong and weak acids show that analyte structure had a similar effect on the 
complexation process for both groups of analytes.  Except for mandelic acid, all weak 
acid analytes were much larger than the phenylsulfopropanes, which were resolved with 
HMBCD.  Therefore, it could be argued that in the case of weak acid analytes, size may 
have hindered inclusion complexation with HMBCD, because the effective cavity size of 
HMBCD is diminished by the morpholinium substituent groups. 
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Figure 50. Effective mobilities of the enantiomers of weak acid analytes in pH = 9.3 BE 
with HMBCD.  
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3.2 Separations with PEMEDA-BCD 
According to the CHARM model [49], the higher the effective charge (zeff) of the 
charged cyclodextrin (CCD), the higher the peak resolution with all other conditions 
being equal.  The minimum number of effective charges a CCD may have is 1.  
Therefore, assuming a 1:1 stiochiometry for complexation between a monoanionic chiral 
analyte, and a CCD with zeff = 1, the net charge of the resulting analyte-CD complex is 
zero.  In such a situation, the analyte-CD complex will migrate with the electroosmotic 
flow.  But under the same analytical conditions, complexation between the monoanionic 
analyte and a dicationic cyclodextrin will result in an analyte-CD complex with a net 
charge of one, i.e., the complex will migrate cationically.  PEMEDA-BCD has two 
quaternary ammonium groups linked to one of the glucose units of CD, giving it the 
properties of a strong electrolyte. 
 
3.2.1 Materials 
Some of the analytes were obtained as described earlier in this chapter. 
Phosphoric acid, hydrochloric acid, methanesulfonic acid, ethanolamine, lithium 
hydroxide, benzyltrimethylammonium bromide and p-toluenesulfonic acid were 
purchased from Aldrich Chemical Company (Milwaukee, WI). Mono(6-deoxy-6-
N,N,N′,N′,N′-pentamethylethylenediammonio)-cyclomaltoheptaose chloride (PEMEDA-
BCD) was synthesized and analytically characterized in our laboratory as described in 
Chapter II.  
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3.2.2 Capillary Electrophoretic Methods 
CE measurements were carried out with a P/ACE 2050 and a P/ACE 2100 
instrument, the UV detectors were set to 214 nm. 27 µm i.d., untreated fused-silica 
capillaries (Polymicro Technologies, Phoenix, AZ, USA) with a total length of 26.4 cm 
and injector-to-detector length of 19.6 cm were used. The aqueous stock buffers were 
prepared by titrating a 25 mM solution of phosphoric acid in Milli-Q water (Millipore, 
Milford, MA, USA) to pH 2.54 with lithium hydroxide for the low pH BEs, and by 
titrating a 25 mM solution of ethanolamine to pH 9.30 with methanesulfonic acid for the 
high pH BEs. The stock buffers were used to prepare, daily, the 0-50 mM PEMEDA-
BCD BEs for the CE separations. All solutions were filtered prior to use through a 0.45 
µm Nalgene nylon membrane filter (VWR, South Plainfield, NJ, USA).  The analytes 
were dissolved in the BEs and co-injected for 1 s by 1 psi nitrogen along with the EOF 
marker, DMSO or the external cationic mobility marker, benzyltrimethylammonium 
bromide, or the external anionic mobility marker, p-toluenesulfonic acid, from a solution 
approximately 0.5 mM in both the analyte and the respective marker.  In situations 
where coinjection of the mobility marker was not feasible, the mobility marker was 
injected electrokinetically, separately, from the opposite end of the capillary.  The 
effective mobilities of the external mobility markers, benzyltrimethylammonium 
bromide and p-toluenesulfonic acid in the various PEMEDA-BCD-containing BEs were 
determined using the three-band pressure-mediated CE (PreMCE) method [99]. The 
suitability of DMSO as a neutral marker for this study was experimentally determined as 
described earlier in this chapter.  Figure 51 shows two superimposed UV detector traces 
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of DMSO during the first and second pressure mobilization steps. Since the migration of 
DMSO in both the 50 mM PEMEDA-BCD BE and the chiral resolving agent free BE 
are identical, it was concluded that DMSO does not complex with PEMEDA-BCD at 
concentrations of 50 mM or less.  Electrophoretic currents were measured in the 5, 10, 
20, 30, 40, and 50 mM PEMEDA-BCD BEs to find the highest applied potentials for the 
effective mobility measurements that were still within the linear region of the respective 
Ohm’s plots. To establish that PEMEDA-BCD was stable for enantiomer separations by 
CE, a portion of a 50 mM PEMEDA-BCD BE was stored in the refrigerator and then 
analyzed at intervals, using indirect UV detection CE.  After 90 days, no signs of 
degradation were observed as depicted by the electropherograms shown in Figure 52.  
PEMEDA-BCD was used for the CE separation of the enantiomers of 10 strong 
electrolyte analytes, 17 weak acids, 12 zwitterionic, and 16 nonionic compounds (mostly 
pharmaceuticals) in both low and high pH media. These compounds are part of our 
standard CD evaluation kit, except for the 10 strong electrolytes. The structures of the 
analytes are shown in Figure 46.  The effective mobilities of the enantiomers, µeff1 and 
µeff2, were calculated from µEOF and the observed mobility values, µobs1 and µobs2; using 
equation 10.  Separation selectivities, α, were calculated as α = µeff1 / µeff2; the 
normalized electroosmotic flow mobility values, β, as β = µEOF / µeff2. (Subscript 
assignment followed the arbitrary, but consistent convention introduced in Ref. 49: for a 
combination of monoanionic analytes and a multiply, positively charged resolving agent 
this convention results in separation selectivities that vary between +1 and + infinity as 
long as both enantiomers migrate anionically, it results in separation selectivities that 
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vary between – infinity and 0 as long as one enantiomer migrates cationically and the 
other migrates anionically, and it results in separation  
 
 
 
Figure 51.  UV detector traces of DMSO.  PEMEDA-BCD-free BE before 
electrophoresis (trace A), and 50 mM PEMEDA-BCD-containing BE after 
electrophoresis (trace B). 
 
 
 
A
B
-0.040
-0.020
0.000
0.040
0.020
0.080
0.100
0.060
A
bs
or
ba
nc
e 
/ A
U
1 3 4 5 62
Time / min
 112
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 52.  Indirect UV-detection electropherograms of a 50 mM PEMEDA-BCD 
solution.  (A) fresh solution; (B) after 90 days.  
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selectivities that vary between 0 and +1 once both enantiomers migrate cationically).  
Peak resolution was calculated using the peak width at half height method, equation 11. 
 
3.2.3 Results and Discussion 
The next seven tables list the effective mobilities of the less mobile enantiomers, 
µ (the average of three measurements, typical RSD values less than 3%), the separation 
selectivities, α, the peak resolution values, Rs, the normalized EOF mobility values, β, 
and the injector-to-detector potential drop values, U (in kV), obtained in the PEMEDA-
BCD BEs. When effective mobility data could not be calculated because of an overlap 
with a non-comigrating system peak, the neutral marker peak or the ionic mobility 
marker peak, an entry of N/A is used in the tables.  Over the 1 to 20 mM PEMEDA-
BCD concentration range, the µEOF values were in the (-4) H10-5 cm2V-1s-1 to (7) H10-5 
cm2V-1s-1 range for the acidic aqueous PEMEDA-BCD-containing BEs and in the (-
2)H10-5 cm2V-1s-1 to (10) H10-5 cm2V-1s-1 range for the basic aqueous PEMEDA-BCD-
containing BEs. In both cases, the negative µEOF values indicate that the walls of the 
capillary were partially covered by PEMEDA-BCD.  
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3.2.3.1 Separation of the Enantiomers of Strong Electrolyte Analytes with 
PEMEDA-BCD in Low pH BEs 
Table 3 shows the results obtained for the O-sulfo test analytes. Since the charge 
of the O-sulfo test analytes does not change as the pH of the BE is increased from 2.54 
to 9.30, detailed studies were only carried out in the acidic BEs by varying the 
concentration of PEMEDA-BCD in the 1 to 20 mM range. In the absence of PEMEDA-
BCD, the newly synthesized monoanionic analytes (S1-S8, S10) have effective 
mobilities in the –(15 to 30) x 10-5 cm2V-1s-1 range, while the effective mobility of the 
dianionic analyte, S9 is about twice as high, –53 x 10-5 cm2V-1s-1, as expected. In the 
absence of PEMEDA-BCD, for the same substitution pattern, the effective mobilities 
decreased as the length of the alkyl chain of the O-sulfo-alkanes was increased (compare 
S01, S04 and S07 for the 1-phenyl-1-O-sulfo-alkanes; S02 and S05 for the 2-phenyl-1-
O-sulfo-alkanes, and S03, S06 and S08 for the 1-phenyl-2-O-sulfo-alkanes). The 
mobility decrease per methylene unit was about 2-to-3 times higher for the 1-O-sulfo 
derivatives than for the 2-O-sulfo derivatives (compare the S01, S04 and S07 series, and 
the S02 and S05 series with the S03, S06 and S08 series). In the absence of PEMEDA-
BCD, for the same alkyl chain length, the effective mobilities decreased as the 
substitution pattern went from 1-phenyl-1-O-sulfo-alkanes to 2-phenyl-1-O-sulfo-
alkanes to 1-phenyl-2-O-sulfo-alkanes (compare S01, S02 and S03 for the propane 
derivatives, S04, S05 and S06 for the butane derivatives, and S07 and S08 for the 
pentane derivatives), indicating an increase in the hydrated ion radii of the  
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Table 3.   
 
Separation data for strong electrolyte analytes as a function of PEMEDA-BCD 
concentration in pH = 2.5 BE.  µ in (10-5 cm2 V-1s-1) units.+ 
 
 
PEMEDA- BCD 
(mM) 
0   2    5  
U (kV)    -15    15  
Analyte : : " $ Rs : " $ Rs 
S01 -31.7 -23.4 1.04 -0.8 1.1 -0.26 1.24 -26 1.1 
S02 -29.6 -14.5 1.00 -0.2 0.0 6.46 1.00 0.6 0.0 
S03 -25.3 1.57* 0.74 2.4 1.5 4.99 0.92 0.5 1.2 
S04 -25.9 -12.9 1.05 -0.6 3.2 0.45 0.84 9.3 1.3 
S05 -23.8 -15.0 1.00 -0.4 0.0 4.28 1.00 0.9 0.0 
S06 -22.5 1.49* 0.75 1.5 1.7 4.63 0.89 0.5 1.9 
S07 -22.5 -16.6 1.17 -0.4 0.8 0.85 0.83 0.0 1.1 
S08 -19.4 -13.4 1.06 -1.2 1.4 4.69 0.84 0.8 0.9 
S09 -53.0 -44.2 1.01 -0.5 0.2 -26.7 1.01 -0.2 <0.6 
S10 -28.2 -13.2 1.05 -0.4 1.2 0.26 0.81 17.5 3.2 
 
 
* 18 kV 
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Table 3.  Continued 
 
 
PEMEDA- BCD 
(mM) 
0   10    20  
U (kV)    9    9  
Analyte : : " $ Rs : " $ Rs 
S01 -31.7 3.64 0.90 0.0 3.5 4.10 0.92 -0.2 2.9 
S02 -29.6 8.09 1.00 0.0 0.0 8.95 1.00 -0.4 0.0 
S03 -25.3 5.58 0.95 0.0 1.5 5.64 0.97 -0.3 1.5 
S04 -25.9 3.00 0.88 -0.4 5.2 4.08 0.91 -0.5 5.2 
S05 -23.8 6.48 1.00 0.0 0.0 7.29 1.00 -0.4 0.0 
S06 -22.5 5.19 1.00 0.0 0.0 5.14 1.00 -0.3 0.0 
S07 -22.5 4.63 0.94 0.0 0.8 4.98 0.93 -0.4 0.6 
S08 -19.4 7.00 0.97 -0.2 1.7 8.07 0.98 -0.3 1.1 
S09 -53.0 -12.4 1.04 0.2 <0.6 -9.82 1.03 0.4 0.6 
S10 -28.2 3.40 0.88 0.0 2.2 4.74 0.96 -0.2 1.3 
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O-sulfo ions.  The increase was smaller for the 2-phenyl-, larger for the 2-O-sulfo 
pattern. 
Once PEMEDA-BCD was added to the BE, the anionic effective mobilities 
decreased as the PEMEDA-BCD concentration was increased, they became cationic 
(except for S9, which is a dianion) and increased further without reaching the limiting 
mobilities by 20 mM, the highest PEMEDA-BCD concentration tested here. This 
behavior indicates that PEMEDA-BCD interacts with the 1-phenyl-1-O-sulfo-alkanes 
less strongly than with the 2-phenyl-1-O-sulfo-alkanes and the 1-phenyl-2-O-sulfo-
alkanes (compare the mobilities for the S01, S04 and S07 series with those of the S02 
and S05 series, and the S03, S06 and S08 series). It is remarkable that the enantiomers of 
2-phenyl-1-O-sulfo-propane (S02) and 2-phenyl-1-O-sulfo-butane (S05) were not 
resolved in the entire 0 to 20 mM PEMEDA-BCD concentration range, despite the fact 
that the $ values were quite favorable. While one could speculatively invoke differences 
in the inclusion patterns, the true explanation will have to come from detailed NMR 
spectroscopic studies. Fortunately, since PEMEDA-BCD recently became available in 
adequate quantities, such studies are now possible. Overall, the effective mobility and 
separation selectivity patterns observed for S1 to S10 follow the predictions of the 
CHARM model [49] corrected for the ionic strength effects [44]. As typical examples, 
the mobility and separation selectivity curves of S01, S04 and S08 are shown in Figure 
53.  Separation selectivities are the best in the vicinity of the PEMEDA-BCD 
concentration where the effective mobilities change from anionic to cationic values. 
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Figure 53.  Effective mobilities (top portion) and separation selectivities (bottom 
portion) for the enantiomers of the strong electrolyte analytes.  pH = 2.5 PEMEDA-BCD 
BE. 
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Table 4.   
 
Separation data for weak acid analytes as a function of PEMEDA-BCD concentration in 
pH = 2.5 BE.  µ in (10-5 cm2 V-1s-1) units. 
 
 
PEMEDA- 
BCD (mM) 
0   1    2  
U (kV)    12    12  
Analyte : : " $ Rs : " $ Rs 
A01 -3.17 -1.70 1.00 -1.9 0.0 -1.17 1.00 -3.6 0.0 
A02 0.0 13.2 1.00 0.4 0.0 14.2 1.00 0.3 0.0 
A03 0.0 6.82 1.00 0.3 0.0 14.7 1.00 0.6 0.0 
A04 0.0 3.48 1.00 1.5 0.0 6.70 1.00 0.6 0.0 
A05 0.0 13.4 1.00 0.5 0.0 14.2 1.00 0.3 0.0 
A07 0.0 10.5 1.00 0.4 0.0 12.0 1.00 0.4 0.0 
A09 0.0 10.8 1.04 0.6 1.5 12.5 1.03 0.3 1.2 
A12 0.0 10.2 1.03 0.7 0.6 12.6 1.04 0.3 1.0 
A13 0.0 5.58 1.00 1.2 0.0 8.68 1.00 0.4 0.0 
A14 0.0 0.69 1.00 5.6 0.0 1.2 1.00 3.3 0.0 
A15 0.0 5.38 1.07 1.0 <0.6 7.29 1.06 3.7 <0.6 
A16 0.0 5.42 1.16 4.5 2.8 7.64 1.14 4.1 3.7 
A17 0.0 0.86 1.23 8.2 0.9 1.59 1.22 3.4 1.9 
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Table 4. Continued 
 
 
PEMEDA-
BCD (mM) 
0   3    5  
U (kV)    12    12  
Analyte : : " $ Rs : " $ Rs 
A01 -3.17 -0.19 1.00 -17 0.0 0.53 1.13 5.5 <0.6 
A02 0.0 16.1 1.00 0.2 0.0 15.2 1.00 0.3 0.0 
A03 0.0 16.3 1.00 0.2 0.0 17.5 1.00 -0.2 0.0 
A04 0.0 8.75 1.00 0.5 0.0 9.70 1.00 0.4 0.0 
A05 0.0 16.4 1.00 0.3 0.0 13.8 1.00 -0.2 0.0 
A07 0.0 14.0 1.00 0.3 0.0 13.8 1.00 -0.2 0.0 
A09 0.0 13.1 1.02 0.2 1.0 13.5 1.02 -0.2 0.8 
A12 0.0 13.6 0.04 0.2 1.8 13.9 1.08 0.2 0.9 
A13 0.0 10.7 1.00 0.4 0.0 12.3 1.02 0.3 0.0 
A14 0.0 1.62 1.00 2.6 0.0 2.18 1.00 1.2 0.0 
A15 0.0 8.21 1.06 0.5 0.6 10.3 1.05 0.4 0.7 
A16 0.0 9.36 1.11 4.0 3.7 10.8 1.09 0.4 2.5 
A17 0.0 2.35 1.20 4.5 2.8 3.44 1.20 1.2 3.4 
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Table 4. Continued 
 
 
PEMEDA-
BCD (mM) 
0   10    20  
U (kV)    12    9  
Analyte : : " $ Rs : " $ Rs 
A01 -3.17 1.79 1.12 1.3 0.8 1.90 1.09 0.8 1.3 
A02 0.0 14.5 1.00 -0.5 0.0 12.8 1.00 -0.3 0.0 
A03 0.0 15.3 1.00 -0.6 0.0 13.0 1.00 -0.1 0.0 
A04 0.0 13.0 1.00 -0.3 0.0 12.0 1.00 -0.3 0.0 
A05 0.0 13.0 1.00 0.1 0.0 11.8 1.00 -0.2 0.0 
A07 0.0 13.6 1.00 0.1 0.0 12.2 1.00 -0.1 0.0 
A09 0.0 15.0 1.01 -0.5 0.8 12.5 1.00 -0.2 0.0 
A12 0.0 13.6 1.00 0.2 0.0 13.0 1.00 -0.3 0.0 
A13 0.0 13.5 1.00 0.1 0.0 12.6 1.00 -0.3 0.0 
A14 0.0 4.00 1.00 0.2 0.0 4.89 1.00 0.3 0.0 
A15 0.0 12.2 1.02 0.1 0.8 11.7 1.01 -0.1 0.5 
A16 0.0 11.9 1.04 0.1 2.4 11.6 1.03 -0.2 1.7 
A17 0.0 6.00 1.15 0.2 5.8 7.90 1.14 -0.2 6.6 
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3.2.3.2 Separation of the Enantiomers of the Weak Acid Analytes with PEMEDA-
BCD in Low pH BEs 
In the low pH BEs, where all weak acids are nondissociated (except mandelic 
acid, A01), the effective mobilities became cationic even at low PEMEDA-BCD 
concentrations and passed the expected shallow mobility maxima, except ethosuximide 
(A14) and indapamide (A17) whose effective mobilities remained about one half of what 
was observed for the other weak acid analytes, indicating a much weaker interaction 
with PEMEDA-BCD.  For all the analytes, their effective mobilities ranged from a low 
of 3x10-5 cm2V-1s-1 in 1 mM PEMEDA-BCD to a limiting high value of 13x10-5 cm2V-
1s-1 in the 20 mM PEMEDA-BCD BEs.  Typical examples of the effective mobility 
curves are shown in Figure 54, top panel.  Despite the strong interaction of most of the 
analytes with PEMEDA-BCD, enantioseparation was achieved only for five of the 
seventeen weak acids studied, even though the β values were quite reasonable (see Table 
4).  
Thus, in agreement with the dictums of the CHARM model [49], both low and 
high pH BEs need to be explored for the separation of the enantiomers of weak acid 
analytes, though the separation selectivity values are typically better when the effective 
mobilities of the analytes can go from anionic to cationic in the high pH BEs. As typical 
examples, separation selectivity curves for representatives of the weak acid analytes are 
shown in Figure 54, bottom panel, for the low pH BEs. 
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Figure 54.  Typical effective mobility and separation selectivity curves for the 
enantiomers of weak acid analytes with PEMEDA-BCD in pH = 2.5 BEs. 
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3.2.3.3 Separation of the Enantiomers of Nonionic Analytes with PEMEDA-BCD in 
Low pH BEs 
For the nonionic analytes, the effective cationic mobilities increased as the 
concentration of PEMEDA-BCD was increased, but remained low for the weakly 
complexing enantiomers, and only reaching a value of 13×10-5 cm2/Vs for the more 
strongly complexing enantiomers in 20 mM PEMEDA-BCD BEs as shown in Table 5.  
Typical effective mobility curves are shown in the top panel of Figure 55, for the 
strongly and weakly complexing analytes. 
The enantiomers of eight of the sixteen nonionic compounds tested in the low pH 
PEMEDA-BCD BEs were separated. It is interesting to see that only the analytes with 
the hydroxy group attached directly to the chiral carbon atom and one bond away from 
the aromatic ring were separated, indicating the influence of the aromatic ring on the 
inclusion complexation between the analytes and the PEMEDA-BCD.  The 
corresponding separation selectivities increased to a maximum (at very low PEMEDA-
BCD concentrations for the more strongly complexing enantiomers) and then decreased 
slowly as the concentration of PEMEDA-BCD was increased (Figure 55, bottom panel), 
in agreement with the predictions of the CHARM model [49]. 
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Table 5.   
 
Separation data for neutral analytes as a function of PEMEDA-BCD concentration in pH 
= 2.5 BE.  µ in (10-5 cm2 V-1s-1) units. 
 
 
PEMEDA- 
BCD (mM) 
0   1    2  
U (kV)    15    10  
Analyte : : " $ Rs : " $ Rs 
N01 0.0 1.98 1.00 4.2 0.0 3.24 1.08 1.6 0.7 
N02 0.0 3.32 1.00 1.8 0.0 5.77 1.00 0.8 0.0 
N03 0.0 2.29 1.00 2.7 0.0 4.28 1.00 1.3 0.0 
N04 0.0 3.21 1.10 2.9 <0.6 5.05 1.08 0.7 1.1 
N05 0.0 4.75 1.00 1.3 0.0 7.03 1.00 0.5 0.0 
N06 0.0 5.08 1.00 1.7 0.0 7.58 1.13 0.6 <0.6 
N07 0.0 3.94 1.00 1.9 0.0 6.17 1.02 0.6 <0.6 
N08 0.0 3.64 1.00 2.2 0.0 6.07 1.03 0.5 4.0 
N09 0.0 5.47 1.00 1.4 0.0 6.20 1.00 0.6 0.0 
N10 0.0 6.06 1.00 1.4 0.0 8.45 1.00 0.6 0.0 
N11 0.0 0.96 1.00 6.2 0.0 1.65 1.00 3.3 0.0 
N12 0.0 0.18 1.00 12.9 0.0 0.82 1.00 4.0 0.0 
N13 0.0 0.66 1.00 8.4 0.0 1.21 1.12 3.1 1.1 
N14 0.0 0.30 1.00 18.3 0.0 1.31 1.13 2.9 0.8 
N15 0.0 6.00 1.20 1.2 4.4 7.91 1.15 0.5 4.4 
N16 0.0 1.83 1.00 4.7 0.0 3.47 1.04 1.0 <0.6 
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Table 5. Continued 
 
 
PEMEDA- 
BCD (mM) 
0   3    5  
U (kV)    10    10  
Analyte : : " $ Rs : " $ Rs 
N01 0.0 5.15 1.07 0.9 0.7 7.07 1.04 0.5 1.3 
N02 0.0 7.82 1.00 0.4 0.0 9.80 1.00 0.3 0.0 
N03 0.0 6.58 1.00 0.8 0.0 8.75 1.00 0.6 0.0 
N04 0.0 7.01 1.08 0.4 0.9 8.76 1.06 0.4 0.8 
N05 0.0 9.23 1.00 0.5 0.0 11.2 1.00 0.3 0.0 
N06 0.0 9.94 1.02 0.3 <0.6 11.4 1.02 0.3 <0.6 
N07 0.0 8.46 1.02 0.4 <0.6 10.4 1.01 0.3 <0.6 
N08 0.0 7.19 1.11 0.6 <0.6 9.77 1.02 0.4 <0.6 
N09 0.0 8.61 1.00 0.3 0.0 11.4 1.00 0.3 0.0 
N10 0.0 10.8 1.00 0.4 0.0 12.0 1.00 0.3 0.0 
N11 0.0 2.37 1.00 1.8 0.0 3.20 1.00 1.1 0.0 
N12 0.0 1.42 1.00 3.0 0.0 2.29 1.04 1.3 <0.6 
N13 0.0 1.95 1.10 2.4 0.9 2.76 1.10 1.3 0.8 
N14 0.0 2.28 1.11 1.5 1.4 3.05 1.11 1.2 1.3 
N15 0.0 10.1 1.12 0.5 4.3 11.5 1.09 0.3 3.6 
N16 0.0 5.27 1.04 0.5 <0.6 6.87 1.03 0.5 <0.6 
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Table 5. Continued 
 
 
PEMEDA- 
BCD (mM) 
0   10    20  
U (kV)    9    9  
Analyte : : " $ Rs : " $ Rs 
N01 0.0 9.26 1.04 0.1 0.9 9.63 1.03 -0.4 1.2 
N02 0.0 11.7 1.00 0.1 0.0 12.2 1.00 -0.3 0.0 
N03 0.0 9.50 1.00 0.1 0.0 10.3 1.00 -0.3 0.0 
N04 0.0 11.5 1.03 -0.1 1.5 12.1 1.02 -0.4 1.1 
N05 0.0 12.5 1.00 0.1 0.0 13.2 1.00 0.3 0.0 
N06 0.0 12.4 1.00 0.1 0.0 12.8 1.00 -0.3 0.0 
N07 0.0 11.4 1.01 0.1 0.6 11.9 1.00 -0.3 0.0 
N08 0.0 11.8 1.01 0.1 0.6 12.3 1.00 0.3 0.0 
N09 0.0 12.9 1.00 0.1 0.0 12.5 1.00 -0.3 0.0 
N10 0.0 12.8 1.00 0.1 0.0 13.1 1.00 -0.3 0.0 
N11 0.0 6.07 1.01 -0.2 0.6 7.31 1.01 -0.6 0.6 
N12 0.0 3.97 1.23 0.3 0.9 4.93 1.05 -0.6 0.6 
N13 0.0 4.88 1.08 0.1 1.5 6.40 1.07 -0.6 1.1 
N14 0.0 5.33 1.08 0.1 2.2 7.85 1.07 -0.5 7.3 
N15 0.0 12.3 1.05 0.1 2.6 12.7 1.03 -0.3 1.9 
N16 0.0 8.90 1.02 0.2 0.6 10.3 1.01 -0.3 <0.6 
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Figure 55.  Effective mobility and separation selectivity curves for the enantiomers of 
nonionic analytes with PEMEDA-BCD in pH =2.5 BEs. 
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3.2.3.4 Separation of the Enantiomers of Weak Base Analytes with PEMEDA-BCD 
in Low pH BEs 
Although PEMEDA-BCD was designed for the separation of anionic analytes, an 
attempt was made to separate the enantiomers of cationic analytes as well.  A set of five 
basic test analytes was studied in low pH BEs containing various concentrations of 
PEMEDA-BCD.  The results obtained are shown in Table 6.  The effective mobilities, in 
the absence of PEMEDA-BCD, ranged from 21×10-5 cm2/Vs to 30 ×10-5 cm2/Vs, as 
expected, because at pH 2.5 all weak base analytes were protonated.  Because the 
analytes were positively charged, they migrated in the same direction as PEMEDA-
BCD, toward the cathode, and complexation was not favored due to ionic repulsion 
between the positively charged analytes and the positively charged chiral resolving 
agent.  Upon addition of the chiral resolving agent into the BE, the cationic effective 
mobilities of the enantiomers of the five basic analytes decreased by an average of three 
mobility units as the concentration of PEMEDA-BCD was increased.  The observed 
decrease in mobility could be due to the effects of increased ionic strength and viscosity.  
For example, the cationic mobility of methoxyphenamine (B01), dropped from 20.7 
mobility unit in a BE with no chiral resolving agent to 19.0 mobility units in a 20 mM 
PEMEDA-BCD BE, indicating the absence of complexation between the basic analyte 
and the cationic chiral resolving agent.  Consequently, no separation of the enantiomers 
was obtained for this class of analytes with PEMEDA-BCD. 
Typical electropherograms for the enantiomers of strong electrolytes, weak acids, 
and neutral analytes obtained with PEMEDA-BCD in the low pH BE are depicted in 
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Figures 56 and 57.  The numbers and letters beside the peaks correspond to those used to 
identify the analytes (see Figure 46), while the values in parenthesis indicate the 
concentrations of PEMEDA-BCD used to obtain the separations.  Good resolutions were 
observed for the strong electrolytes, as well as the nonionic analytes in the low pH BE. 
 
 
 
Table 6.   
 
Separation data for weak base analytes as a function of PEMEDA-BCD concentration in 
pH = 2.5 BE.  µ in (10-5 cm2 V-1s-1) units. 
 
 
PEMEDA-
BCD (mM) 
0   1    2  
U (kV)    18    18  
Analyte µ µ α β Rs µ α β Rs 
B01 20.7 21.1 1.00 0.3 0.0 21.2 1.00 0.2 0.0 
B02 29.7 30.1 1.00 0.2 0.0 30.1 1.00 0.2 0.0 
B03 23.2 24.3 1.00 0.5 0.0 24.1 1.00 0.2 0.0 
B04 22.0 22.5 1.00 0.3 0.0 22.6 1.00 0.2 0.0 
B05 22.2 22.8 1.00 0.3 0.0 22.6 1.00 0.2 0.0 
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Table 6. Continued 
 
 
PEMEDA-
BCD (mM) 
0   5    10  
U (kV)    15    12  
Analyte µ µ α β Rs µ α β Rs 
B01 20.7 20.1 1.00 0.1 0.0 20.3 1.00 0.0 0.0 
B02 29.7 28.8 1.00 0.1 0.0 26.5 1.00 0.0 0.0 
B03 23.2 23.4 1.00 0.1 0.0 21.6 1.00 0.0 0.0 
B04 22.0 21.3 1.00 0.1 0.0 21.1 1.00 0.0 0.0 
B05 22.2 22.0 1.00 0.1 0.0 20.8 1.00 0.0 0.0 
 
 
 
 
 
 
 
 
 
 
Table 6. Continued 
 
 
PEMEDA-
BCD (mM) 
0   20  
U (kV)    12  
Analyte µ µ α β Rs 
B01 20.7 19.0 1.00 -0.1 0.0 
B02 29.7 24.6 1.00 -0.1 0.0 
B03 23.2 19.5 1.00 -0.2 0.0 
B04 22.0 18.9 1.00 -0.1 0.0 
B05  22.2 18.7 1.00 -0.1 0.0 
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Figure 56.  Typical electropherograms for the enantiomers of the weak acid and neutral 
analytes with PEMEDA-BCD in pH = 2.5 BEs. 
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Figure 57.  Typical electropherograms for the enantiomers of strong electrolytes with 
PEMEDA-BCD in pH = 2.5 BEs. 
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3.2.3.5 Separation of the Enantiomers of Weak Acid Analytes with PEMEDA-BCD 
in High pH BEs 
Since PEMEDA-BCD showed excellent enantiorecognition for both strong 
electrolytes and nonionic analytes in the low pH BE, there was good reason to extend the 
studies to high pH where all the weak acids will be deprotonated, which might lead to 
favorable conditions for chiral resolution.  Table 7 shows the results obtained for the 
weak acid test analytes in the high pH PEMEDA-BCD BEs. It is well known [49] that 
separation selectivities for weak electrolyte analytes can be different in their dissociated 
and nondissociated forms (i.e., the separations can be desionoselective, ionoselective and 
duoselective [49]). Therefore, the weak acid analytes were tested both in the pH = 2.54 
BEs (Table 4), where they were nondissociated (except mandelic acid, A01), and in the 
pH = 9.30 BEs, where they were fully dissociated (except indapamide, A17).  In the high 
pH BE, in the absence of PEMEDA-BCD, the effective mobilities of the weak acid 
analytes varied in the - (22 to 35) x 10-5 cm2 V-1s-1 range, which is reasonable in light of 
their structure and charge. 
For the group of the 2-phenylacetic acid derivatives (A01 to A03), the effective 
mobilities remained highly anionic for the hydrophylic 2-hydroxy derivative (A01), even 
at a PEMEDA-BCD concentration of 20 mM, while the effective mobilities of the 2-
cyclopentyl (A02) and 2-cyclohexyl (A03) derivatives became cationic even with such a 
low PEMEDA-BCD concentration as 3 mM. At a high enough PEMEDA –BCD 
concentration (above 5 mM), the effective mobilities of A02 and A03 became close to 
each other, and slightly decreased with increasing PEMEDA-BCD concentration, due  
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Table 7. 
Separation data for weak acid analytes as a function of PEMEDA-BCD concentration in 
pH = 9.3 BE.  µ in (10-5 cm2 V-1s-1) units. 
 
 
PEMEDA- 
BCD (mM) 
0   1    3  
U (kV)    18    15  
Analyte : : " $ Rs : " $ Rs 
A01 -35.4 -32.1 1.00 -0.2 0.0 -27.9 1.02 -0.1 <0.6 
A02 -24.2 -3.14 1.20 -2.6 1.3 1.86 0.88 2.3 1.6 
A03 -23.2 1.84 0.56 8.0 1.5 5.71 0.94 0.7 1.0 
A04 -28.6 -28.4 1.00 -0.4 0.0 -22.6 1.03 -0.2 1.2 
A05 -23.4 6.37 1.00 0.8 0.0 9.21 0.94 0.4 1.0 
A06 -23.4 5.41 0.98 1.1 0.6 8.48 1.00 0.4 0.0 
A07 -23.2 2.19 0.91 2.5 1.5 5.76 0.98 0.9 <0.6 
A08 -22.7 -3.32 1.10 -1.9 1.5 1.04 0.85 3.5 1.1 
A09 -24.1 -2.86 1.11 -2.1 1.3 1.40 0.86 2.9 0.9 
A10 -21.9 -1.92 1.09 -4.4 <0.6 4.94 0.97 0.8 <0.6 
A11 -30.0 -21.1 1.01 -0.3 <0.6 -13.9 1.05 -0.2 1.5 
A12 -27.5 -16.1 1.05 -0.5 1.0 -5.89 1.16 -0.6 4.7 
 -27.5 -14.3 1.04 -0.5 0.7 N/A N/A N/A N/A 
A13 -27.6 -18.8 1.05 -0.4 1.6 -4.42 1.16 -0.5 4.8 
A16 -27.5 -20.1 1.02 -0.4 1.3 -13.1 1.06 -0.2 1.7 
A17 -7.9 -4.46 1.04 -1.8 1.8 -2.93 1.16 -0.8 3.8 
 
 
 
 
 
 
 
 136
 
 
 
Table 7. Continued 
 
 
PEMEDA-
BCD (mM) 
0   5    10  
U (kV)    15    12  
Analyte : : " $ Rs : " $ Rs 
A01 -35.4 -25.1 1.03 -0.1 1.1 -18.1 1.05 0.1 1.4 
A02 -24.2 4.21 0.95 0.4 1.1 4.00 0.97 0.5 0.8 
A03 -23.2 6.54 0.95 0.3 1.1 5.56 0.98 0.3 0.9 
A04 -28.6 -14.8 1.05 -0.2 1.6 -13.4 1.08 0.2 1.1 
A05 -23.4 9.10 0.99 0.3 <0.6 8.79 1.00 0.2 0.0 
A06 -23.4 8.80 1.00 0.23 0.0 7.62 1.00 0.3 0.0 
A07 -23.2 6.78 1.00 0.4 <0.6 5.71 1.00 0.3 0.0 
A08 -22.7 3.06 0.94 0.7 1.1 3.68 0.97 0.5 0.8 
A09 -24.1 3.97 0.96 0.4 0.9 3.93 0.98 0.5 0.7 
A10 -21.9 6.31 0.99 0.2 0.7 5.50 1.00 0.3 0.0 
A11 -30.0 -10.5 1.05 -0.1 2.2 -5.79 1.08 0.4 3.2 
A12 -27.5 N/A N/A N/A N/A 2.12 0.90 1.2 1.9 
 -27.5 N/A N/A N/A N/A 1.15 0.77 2.2 3.4 
A13 -27.6 N/A N/A N/A N/A 0.81 0.65 3.1 4.1 
A16 -27.5 -9.45 1.08 -0.2 3.6 3.75 0.81 0.7 1.30 
A17 -7.9 N/A N/A N/A N/A 6.83 0.47 4.5 6.9 
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Table 7. Continued 
 
   
PEMEDA-
BCD (mM) 
0   20  
U (kV)    10  
Analyte : : " $ Rs 
A01 -35.4 -17.6 1.06 -0.1 2.0 
A02 -24.2 N/A N/A N/A N/A 
A03 -23.2 N/A N/A N/A N/A 
A04 -23.2 N/A N/A N/A N/A 
A05 -23.4 N/A N/A N/A N/A 
A06 -23.4 N/A N/A N/A N/A 
A07 -23.2 N/A N/A N/A N/A 
A08 -22.7 N/A N/A N/A N/A 
A09 -24.1 N/A N/A N/A N/A 
A10 -21.9 N/A N/A N/A N/A 
A11 N/A N/A N/A N/A N/A 
A12 -27.5 2.46 0.96 0.3 1.4 
 -27.5 1.89 0.91 0.4 2.9 
A13 -27.6 1.59 0.87 0.5 3.1 
A16 -27.5 4.00 0.84 0.2 4.5 
A17 -7.9 8.95 0.75 0.3 9.7 
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to the increased ionic strength and viscosity of the BE. This migration behavior suggests 
that hydrophobic interactions are important for A02 and A03, and are stronger for the 2-
cyclohexyl derivative (A03) than for the 2-cyclopentyl derivative (A02).   
For the profens (A04 to A10), 2-phenylpropionic acid (A04) showed a 
surprisingly weak interaction with PEMEDA-BCD: its effective mobility went from -28 
mobility units at 0 mM PEMEDA-BCD to only -13 mobility units at 10 mM PEMEDA-
BCD, while ibuprofen (A05) and flurbiprofen (A06) went from an initial value of about -
23 mobility units at 0 mM PEMEDA-BCD to about 7 mobility units at 10 mM 
PEMEDA-BCD. Though the other profens (fenoprofen, A07, ketoprofen, A08, 
naproxene, A09 and carprofen, A10) interacted a little less strongly with PEMEDA-
BCD than ibuprofen and flurbiprofen, their effective mobilities also became cationic by 
10 mM PEMEDA-BCD. For all the profens that eventually migrated cationically, the 
cationic effective mobilities passed a shallow maximum as the PEMEDA-BCD 
concentration was increased, again as a result of the increased ionic strength and 
increased viscosity of the BEs.  The rest of the weak acid analytes studied (A11 through 
A17) have more varied structural features and cannot be as readily categorized as the 2-
phenylacetic acid and 2-phenylpropionic acid derivatives. For some of them, such as 
A11, the effective mobilities remained anionic in the entire PEMEDA-BCD 
concentration range, for others, such as A16, the interactions between the analyte and 
PEMEDA-BCD were as strong as for the profens. 
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As far as separation selectivity and peak resolution go, both α and Rs are at their 
best values in the vicinity of the PEMEDA-BCD concentration where the anionic 
effective mobility becomes cationic. This is in agreement with the predictions of the 
CHARM model [49], corrected for ionic strength effects [44].  Typical examples of the 
effective mobility curves and separation selectivities are shown in Figure 58  (the top 
and bottom panels, respectively) for the strongly, moderately, and weakly binding 
enantiomers. 
Typical electropherograms for the enantiomers of the weak acid, obtained with 
PEMEDA-BCD in pH 9.3 BE are shown in Figure 59.  The values on the left column in 
the figures represent the concentration of PEMEDA-BCD for the electropherograms in 
that row, the numbers and the letters beside the peaks correspond to those used in Figure 
46 to identify the analytes.  The anantiomers of all the weak acids were resolved in the 
high pH BE with PEMEDA-BCD. 
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Figure 58. Effective mobilities and separation selectivities for the enantiomers of weak 
acids with PEMEDA-BCD in pH = 9.3 BEs.  Left: strongly binding analytes (effective 
mobility: top panel and separation selectivity: bottom panel).  Right: moderately binding 
and weakly binding analytes (effective mobility: top panel and separation selectivity: 
bottom panel). 
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Figure 59.  Typical electropherograms for the enantiomers of weak acid analytes with 
PEMEDA-BCD in pH = 9.3 BEs. 
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3.2.3.6 Separation of the Enantiomers of Ampholytic Analytes with PEMEDA-BCD 
in High pH BEs 
A series of ampholytic analytes whose ionization states depend on the pH of the 
BE was studied using PEMEDA-BCD. At pH 9.3, all ampholytic analytes were 
deprotonated, anionic, allowing for increased ionic interactions between them and the 
chiral resolving agent.  Table 8 shows the results obtained for the twelve dansylated 
ampholytic test analytes studied with PEMEDA-BCD.  Initially, in the BEs without 
PEMEDA-BCD, all enantiomers of this group of analytes had anionic effective 
mobilities ranging from –17.3 mobility unit for DNS-caprylic acid to –34.0 mobility 
units for DNS-glutamic acid.  This agrees with data already reported for this group of 
analytes in their fully deprotonated forms [76].  Following the addition of PEMEDA-
BCD into the BE, the anionic effective mobilities of the analytes decreased.  Similarly to 
what was observed for the weak acid analytes, the anionic effective mobilities continued 
to decrease with an increase in the PEMEDA-BCD concentration, crossed the zero 
mobility line, became cationic, and reached 9.3 x 10-5 cm2 V-1s-1, except for DNS-
aspartic acid and DNS-glutamic acid, which have two negative charges in the high pH 
BEs.  As the concentration of PEMEDA-BCD was increased, the mole fraction of the 
analyte-charged CD complex also increased.  This, in turn, increased the cationic 
effective mobility of the analyte-charged CD complex. However, for the doubly 
negatively charged analytes, the increase in mole fraction did not translate to an equal 
increase in the positive effective charge because the PEMEDA-BCD has only 
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Table 8.   
Separation data for ampholytic analytes as a function of PEMEDA-BCD concentration 
in pH = 9.3 BE.  µ in (10-5 cm2 V-1s-1) units. 
 
 
PEMEDA- 
BCD (mM) 
0   1    3  
U (kV)    18    15  
Analyte : : " $ Rs : " $ Rs 
Z01 -18.6 -14.2 1.03 -0.5 1.3 -5.74 1.10 -0.4 2.7 
Z02 -23.0 -14.2 1.02 -0.5 1.0 -6.48 1.05 -0.5 2.2 
Z03 -24.0 -15.7 1.01 -0.6 <0.6 -9.96 1.01 -0.4 0.6 
Z04 -28.4 -16.7 1.07 -0.4 5.3 -11.4 1.22 -0.3 12.5 
Z05 -25.3 -17.9 1.00 -0.5 0.0 -10.9 1.00 -0.2 0.0 
Z06 -33.7 -25.0 1.03 -0.3 0.9 -13.7 1.06 -0.2 1.5 
Z07 -17.3 -12.7 1.03 -0.6 1.6 N/A N/A N/A N/A 
Z08 -23.4 -15.7 1.02 -0.5 0.8 -8.01 1.07 -0.3 1.5 
Z09 -23.2 -16.0 1.02 -0.5 1.3 -8.31 1.04 -0.3 1.4 
Z10 -34.0 -26.4 1.01 -0.4 <0.6 -15.2 1.03 -0.2 1.8 
Z11 -24.8 -16.0 1.01 -0.5 0.8 -7.81 1.04 -0.2 0.9 
Z12 -18.2 -14.6 1.02 -0.5 0.6 -7.53 1.04 -0.4 0.9 
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Table 8. Continued 
 
 
PEMEDA-
BCD (mM) 
0   5    10  
U (kV)    15    12  
Analyte : : " $ Rs : " $ Rs 
Z01 -18.6 N/A N/A N/A N/A 2.29 0.95 2.4 1.1 
Z02 -23.0 N/A N/A N/A N/A 8.78 0.97 0.6 1.2 
Z03 -24.0 -6.34 1.02 -0.3 1.5 -2.15 1.14 -2.1 2.1 
Z04 -28.4 -8.94 1.33 -0.2 12.8 N/A N/A N/A N/A 
Z05 -25.3 -5.16 1.00 -0.1 0.0 N/A N/A N/A N/A 
Z06 -33.7 -10.8 1.07 -0.3 2.4 -9.22 1.04 -0.6 1.3 
Z07 -17.3 N/A N/A N/A N/A 2.92 0.75 2.3 3.7 
Z08 -23.4 -5.37 1.12 -0.3 2.8 -1.64 1.34 -2.3 2.1 
Z09 -23.2 -5.51 1.08 -0.4 2.5 -1.01 1.41 -3.7 2.1 
Z10 -34.0 -12.2 1.03 -0.2 1.3 -10.3 1.04 -0.5 1.4 
Z11 -24.8 -6.56 1.06 -0.3 2.2 -2.04 1.24 -2.0 3.2 
Z12 -18.2 N/A N/A N/A N/A -0.11 2.64 -14.3 1.4 
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Table 8. Continued 
 
  
PEMEDA-
BCD (mM) 
0   20  
U (kV)    12  
Analyte : : " $ Rs 
Z01 -18.6 2.09 0.95 0.6 1.2 
Z02 -23.0 6.63 0.81 0.2 10.3 
Z03 -24.0 N/A N/A N/A N/A 
Z04 -28.4 N/A N/A N/A N/A 
Z05 -25.3 N/A N/A N/A N/A 
Z06 -33.7 -7.41 1.05 -0.6 2.8 
Z07 -17.3 5.16 0.91 0.1 3.4 
Z08 -23.4 N/A N/A N/A N/A 
Z09 -23.2 0.39 0.91 3.2 0.6 
Z10 -34.0 -8.57 1.03 -0.5 1.3 
Z11 -24.8 N/A N/A N/A N/A 
Z12 -18.2 1.54 0.95 0.3 1.3 
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two positive charges. Thus, DNS-aspartic acid and DNS-glutamic acid could not migrate 
cationically irrespectively of the concentration of PEMEDA-BCD used.  Structural 
differences also affected the degree of complexation between the analytes and the chiral 
resolving agent.  For example, dinitrophenylalanine, the only ampholytic analyte without 
the dansyl group showed the weakest complexation with PEMEDA-BCD.  However, it 
is interesting to see that DNS-phenylalanine, having an unsubstituted aromatic ring close 
to the chiral center showed the strongest complexation with PEMEDA-BCD among all 
the ampholytic analytes, indicating the role of the unsubstituted aromatic ring in the 
inclusion complexation [83,100].  In general, the enantiomers of the twelve ampholytic 
analytes can be classified into three groups: (1) strongly complexed enantiomers whose 
effective mobilities became cationic in the 0 mM to 10 mM PEMEDA-BCD 
concentration range, (2) moderately strongly binding analytes whose effective anionic 
mobilities became cationic in the 10 mM to 20 mM PEMEDA-BCD concentration 
range, and (3) weakly binding analytes whose effective mobilities remained anionic all 
through the PEMEDA-BCD concentration range studied. Figure 60, top panel, shows 
typical effective mobility plots for the enantiomers of each class of ampholytic analytes. 
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The corresponding separation selectivities show trends similar to what were 
observed before, the maximum values occur at the region where the effective mobilities 
cross the zero mobility line (Figure 60, bottom panel), except for DNS-aspartic acid and 
DNS-glutamic acid.The enantiomers of all twelve ampholytic analytes were resolved in 
the pH 9.3 PEMEDA-BCD BE, except for the enantiomers of DNS-methionine.  DNS-
valine showed the highest separation selectivity values, and as expected, the doubly 
charged DNS-glutamic acid exhibited the lowest separation selectivity values in the 
PEMEDA-BCD BE. 
Typical electropherograms for the enantiomers of the ampholytic analytes 
obtained by using PEMEDA-BCD, pH 9.3, BEs are shown in Figure 61.  The values on 
the left column in the figure represent the concentration of PEMEDA-BCD for the 
electropherograms in that row, the numbers and the letters beside the peaks correspond 
to those used in Figure 46 to identify the analytes. Excellent resolution was obtained for 
several of these analytes.  The anantiomers of eleven of the twelve ampholytic analytes 
were resolved in the high pH BE with PEMEDA-BCD. 
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Figure 60.  Effective mobility and separation selectivity curves for the enantiomers of 
the ampholytic analytes with PEMEDA –BCD in pH 9.3 BEs.    
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Figure 61.  Typical electropherograms for the enantiomers of ampholytic analytes with 
PEMEDA-BCD in pH = 9.3 BEs. 
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3.2.3.7 Separation of the Enantiomers of Nonionic Analytes with PEMEDA-BCD in 
High pH BEs 
 Table 9 shows the values obtained for the separation of the enantiomers of nine 
nonionic analytes with PMEDA-BCD in high BE.  At 1 mM PEMEDA-BCD 
concentration, all analytes migrated cationically due to complexation with the chiral 
resolving agent.  Two distinctive types of separations were observed for this group of 
analytes: (1) weakly binding analytes whose cationic effective mobilities varied in the 
range (0.5 to 4.5) x 10-5 cm2 V-1s-1, and (2) strongly binding analytes with effective 
mobilities starting at about 5 x 10-5 cm2 V-1s-1 in 1 mM to 10 x 10-5 cm2 V-1s-1 in 20 mM 
PEMEDA-BCD concentration BEs.  Figure 62, top panel, shows representative mobility 
curves for each type of separation. 
The separation selectivities for the enantiomers of the strongly binding analytes 
shown in Figure 62, bottom panel, decreased with an increase in the concentration of 
PEMEDA-BCD, in agreement with the predictions of the CHARM model [49].  The 
separation selectivities for the enantiomers of the weakly binding analytes increased 
initially, then decreased slowly to a shallow minimum as the concentration of PEMEDA-
BCD was increased in the BE.  High separation selectivities and favorable beta values, 
resulted in separation of the enantiomers of several nonionic analytes studied in the pH 
9.3 PEMEDA-BCD BEs. 
Typical electropherograms for the neutral analytes obtained by using PEMEDA-
BCD, pH 9.3, BEs are shown in Figure 63.  The values on the left column in 
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Table 9.   
Separation data for nonionic analytes as a function of PEMEDA-BCD concentration in 
pH = 9.3 BE.  µ in (10-5 cm2 V-1s-1) units. 
 
 
PEMEDA-
BCD (mM) 
0   1    3  
U (kV)    18    15  
Analyte : : " $ Rs : " $ Rs 
N01 0 1.73 1.21 3.2 1.4 4.24 1.09 0.6 1.1 
N04 0 2.51 1.24 2.0 1.3 5.75 1.10 0.6 1.2 
N07 0 3.41 1.03 2.1 1.6 6.78 1.05 0.4 1.3 
N08 0 3.04 1.19 1.9 1.8 6.33 1.14 0.5 2.5 
N12 0 0.37 1.00 20.3 0.0 1.30 1.04 1.9 0.6 
N13 0 0.51 1.00 14.2 0.0 1.27 1.12 2.0 1.7 
N14 0 0.69 1.07 10.4 <0.6 1.56 1.13 1.6 1.8 
N15 0 3.99 1.22 1.9 4.6 7.82 1.12 0.3 5.8 
N16 0 6.08 1.05 0.9 2.0 9.02 1.05 0.3 2.8 
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Table 9. Continued 
 
 
PEMEDA-
BCD (mM) 
0   5    10  
U (kV)    15    12  
Analyte : : " $ Rs : " $ Rs 
N01 0 5.34 1.06 0.4 1.1 7.00 1.04 0.3 1.6 
N04 0 6.43 1.07 0.3 1.6 7.33 1.05 0.5 0.8 
N07 0 7.79 1.03 0.3 0.8 8.62 1.01 0.2 0.6 
N08 0 7.12 1.09 0.3 2.3 7.57 1.05 0.5 1.3 
N12 0 1.46 1.08 1.4 0.8 1.77 1.09 1.1 1.3 
N13 0 1.57 1.17 14 2.1 2.02 1.15 0.9 2.5 
N14 0 1.98 1.18 1.0 2.7 2.99 1.14 0.6 2.6 
N15 0 8.57 1.09 0.3 4.4 9.49 1.05 0.1 2.6 
N16 0 9.67 1.02 0.2 1.2 9.80 1.01 0.4 0.6 
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Table 9. Continued 
 
   
PEMEDA- 
BCD (mM) 
0   20  
U (kV)    10  
Analyte : : " $ Rs 
N01 0 7.82 1.03 0.0 1.5 
N04 0 7.60 1.03 0.4 1.2 
N07 0 8.77 1.01 0.2 2.2 
N08 0 7.66 1.02 0.4 3.0 
N12 0 1.83 1.12 2.1 1.0 
N13 0 2.34 1.13 1.4 1.8 
N14 0 4.15 1.09 0.1 4.3 
N15 0 9.70 1.03 0.0 2.0 
N16 0 9.91 1.01 0.4 1.0 
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Figure 62.  Effective mobility and separation selectivity curves for the enantiomers of 
nonionic analytes with PEMEDA-BCD in pH 9.3 BEs. 
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Figure 63. Typical electropherograms for the enantiomers of nonionic analytes with 
PEMEDA-BCD in pH = 9.3 BEs. 
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the figure represent the concentration of PEMEDA-BCD for the electropherograms in 
that row, the numbers and the letters beside the peaks correspond to those used in Figure 
46 to identify the analytes.  Over 85% of the neutral analytes were resolved in the high 
pH BE with PEMEDA-BCD. 
 
3.2.4 Comparison of Separation of Enantiomers with HMBCD and PEMEDA-BCD 
BEs 
In principle, with all things being equal, the higher the number of charges on the 
chiral resolving agent, the higher the peak resolution [49].  The major difference 
between HMBCD and PEMEDA-BCD is the number of charges they carry: the former 
has seven positive charges at the C-6 positions, while the later has one C-6 position 
substituted with a doubly positively charged group.  Undoubtedly, the region around the 
cavity of CD is more crowded on HMBCD than on PEMEDA-BCD, which might lead to 
different interactions between the analytes and the chiral resolving agents.  Figure 64 
(top panel) shows the mobility plots obtained with HMBCD and PEMEDA-BCD for two 
anionic analytes (isomers of the newly synthesized phenylsulfopropane).  It is interesting 
to see that their effective mobility trends are similar in shape, indicating similar 
complexation mechanism, with rapid decrease of the anionic effective mobility, reaching 
the limiting values as the concentration was increased.  However, in the 5 mM 
PEMEDA-BCD BE, the anionic effective mobilities have already crossed the zero 
mobility line, and became cationic to level off at 20 mM PEMEDA-BCD concentration.  
For the HMBCD BE, the effective mobilities of the anionic analytes remained anionic 
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all through concentration range studied, indicating that the binding constants for the 
analytes with HMBCD are lower as a result of unfavorable steric influence on the 
inclusion of the analytes into the CD cavity. 
The enantiomers of both analytes were resolved with each of the two chiral 
resolving agents, HMBCD and PEMEDA-BCD.  The corresponding separation 
selectivity plots (Figure 64, bottom section) show that separation selectivity increased to 
a maximum at the region where the anionic effective mobilities crossed the zero mobility 
line for the PEMEDA-BCD system, but for the HMBCD system, selectivity dropped to a 
minimum, then increased slightly at higher CD concentrations.  According to Wren 
[101] the optimum concentration of the chiral selector for a pair of enantiomers is related 
to the stability constants, K, of the diastereomeric complexes by the equation:  
21
1
KK
C =        (12) 
Since low concentrations of PEMEDA-BCD were sufficient to obtain separation of the 
enantiomers of the anions, the stability constants of the diastereomeric complexes of 
PEMEDA-BCD with the anionic analytes could be said to be high compared to the 
stability constants of diastereomeric complexes of HMBCD.         
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Figure 64.  Comparison of separation of enantiomers with HMBCD (block and triangle) 
and PEMEDA-BCD (circle and cross) BEs. 
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CHAPTER IV 
 
CONCLUSIONS 
 
Permanently charged anionic single isomers of cyclodextrins (CD), in addition to 
resolving a broad array of chiral compounds, are important in the understanding of the 
interactions between the chiral selector and the analyte as well as simplifying 
optimization of enantiomer separations.  Only small number of anionic chiral 
compounds were however resolved with these anionic cyclodextrins at high CD 
concentrations.  This limitation has made the understanding of the separation behavior of 
the anionic compounds difficult.  The need for a permanently charged cationic chiral 
resolving agent has led to the synthesis of two new products, heptakis(6-deoxy-6-
morpholinio)-$-cyclodextrin chloride (HMBCD) and  mono(6-deoxy-6-N,N,N′,N′,N′-
pentamethylethylenediammonio)-$-cyclodextrin chloride (PEMEDA-BCD), in the 
family of charged single isomer cyclodextrins.  Apart from their potential for 
enantioresolution of both neutral chiral analytes and anionic chiral analytes, introduction 
of positive charges on the $-CD enhances the solubility of $-CDs in aqueous media. The 
single-isomer cationic $-CDs can provide a very reproducible separation system. 
HMBCD, PEMEDA-BCD, have been synthesized at a large scale by using direct 
substitution without the usual protection group technique at positions C-2 and C-3 of the 
CD.  The key to successful synthesis of these products lies in the selective substitution of 
the hydroxyl groups at C-6 positions of the native $-CD with good leaving groups. The 
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purity of each synthetic intermediate and of the final product was determined by either 
HPLC-ELSD or indirect UV-detection capillary electrophoresis. The chemical and 
structural identity of each single-isomer intermediate and final product was verified by 
1D 1H, 13C, 2D COSY and HMQC NMR spectroscopy and also by high resolution 
MALDI-TOF MS and ESI-TOF MS. These complementary methods proved that 
HMBCD and PEMEDA-BCD are pure and have the characteristics of the targeted 
products. 
A set of ten strong electrolytes was synthesized as test analytes to evaluate the 
utility of HMBCD and PEMEDA-BCD.   The advantages of these new sulfated analytes 
are that they are permanently charged, and can be used at both low and high pH 
background electrolytes (BE). A series of neutral, acidic, basic and ampholytic 
enantiomers were also separated in aqueous BEs.  It was observed that HMBCD 
complexed with the analytes weakly, leading to poor resolution of the enantiomers.  
Strong complexation was observed at low PEMEDA-BCD concentrations with the 
analytes. 
Using HMBCD for separation of anionic analytes at high pH, it was observed 
that the effective mobilities decreased with increasing HMBCD concentration. The 
anionic effective mobility decreased from –29 x 10-5 cm2 V-1s-1 to 1.3 x 10-5 cm2 V-1s-1 
for the multiply, positively charged HMBCD, indicating weak complexation between the 
analytes and HMBCD.   Poor separation selectivities were observed for the enantiomers 
of these analytes with HMBCD.  This poor separation selectivity behavior may have 
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been caused by the steric hindrance from the multiple morpholinio substituents on the 
CD rim. 
 The utility of PEMEDA-BCD as a chiral resolving agent was first tested at low 
pH BE with the newly synthesized strong electrolytes.  The effective mobilities 
decreased from –29 x 10-5 cm2 V-1s-1 to 9 x 10-5 cm2 V-1s-1 at 20 mM PEMEDA-BCD 
concentration.  This is an indication of strong binding between the dicationic PEMEDA-
BCD and the analytes.  Excellent separation selectivies were observed for the 
enantiomers of the strong electrolytes and PEMEDA-BCD.  Over the concentration 
range of PEMEDA-BCD studied in the low pH, the electroosmotic flow mobility (µEOF) 
ranged from –4.0 x 10-5 cm2 V-1s-1 to 7.0 x 10-5 cm2 V-1s-1, most of the weak acids were 
fully undissociated, and therefore behaved like neutral analytes.  Similar separation 
behavior was observed for both weak acid and neutral analytes in low pH BE.  Strong 
complexation between the nonionic analytes and PEMEDA-BCD was observed based on 
their cationic effective mobilities which increased with increase in PEMEDA-BCD 
concentration, and reached a maximum of 13.0 x 10-5 cm2 V-1s-1, which is close to the 
effective mobility of 14.5 x 10-5 cm2 V-1s-1 for the uncomplexed PEMEDA-BCD.  The 
enantiomers of some of the nonionic analytes were resolved, but due to the low µEOF 
longer analysis times were observed. For the cationic analytes, no complexation was 
observed with the PEMEDA-BCD probably due to repulsion between the two. 
In the high pH aqueous PEMEDA-BCD BE all of the weak acids were fully 
dissociated, and the ampholyte analytes were negatively charged.  The µEOF ranged from 
–2 x 10-5 cm2 V-1s-1 to10 * 10-5 cm2 V-1s-1.  The conditions favored the complexation of 
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these analytes with PEMEDA-BCD that resulted in excellent separation of the anionic 
enantiomers at very low concentration of PEMEDA-BCD.  In general, three types of 
separation trends were observed for the anionic analytes in the high pH BE.  (1) For the 
strongly binding analytes the anionic mobilities decreased and crossed the zero mobility 
line and became cationic at below 3 mM PEMEDA concentration.  (2) For the 
moderately strongly binding analytes the anionic effective mobilities crossed the zero 
mobility line at about 10 mM PEMEDA-BCD concentration.  (3) For the weakly binding 
analytes the anionic effective mobilities decreased but did not cross the zero mobility 
line in the PEMEDA-BCD concentration range studied.  This observed separation 
behavior is in agreement with the predicted behavior of separation of anionic enantiomer 
with charged chiral resolving agents reported in ref. 49.  For the nonionic analytes in the 
high pH PEMEDA-BCD BE the observed behavior resembled that seen with PEMEDA-
BCD in the low pH aqueous BE: the cationic effective mobilities increased with an 
increase in the PEMEDA-BCD concentration.  However, shorter analysis time for the 
same concentrations of PEMEDA-BCD was observed in high pH than in low pH BE due 
to an increase in the µEOF at high pH.  In comparison, better separation selectivities were 
seen for the high pH BE than for the low pH BE in all groups of analytes studied 
because of the favorable β values. 
Based on the number of charges, one would have thought that the HMBCD 
would bind the analytes more strongly than the PEMEDA-BCD.  Contrary to the 
predictions, PEMEDA-BCD, having fewer positive charges, showed stronger 
complexation with the anions then HMBCD, and offered excellent enantioresolution.  
 163
 
 
 
This observed trend could only be attributed to the difference in the number of 
substituents on the cyclodextrin rim.  Because only one glucose unit is substituted on 
PEMEDA-BCD and the substitution on the HMBCD is on seven glucose units, the area 
around the CD cavity is less crowded in PEMEDA-BCD than in HMBCD.  Since the 
CD cavity is essential for enantioresolution [98], steric hindrance by the substituents 
would lead to poor enantioresolution. 
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APPENDIX 
 
SYNTHESIS PROTOCOL FOR SINGLE-ISOMER 
QUATERNARY AMMONIUM CYCLODEXTRINS 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 172
 
 
 
Synthesis of Heptakis(6-deoxy-6-iodo)- $-cyclodextrin 
1. Dry native β-cyclodextrin in the vacuum oven at 90°C to a constant weight. 
2. Dissolve 40.1 g of (C6H5)3P in 160 mL of DMF at room temperature while stirring. 
Set the reaction flask in an oil bath at room temperature. 
3. Slowly add 40.5 g of I2 into the flask.  This process is exothermic, so do not let the 
temperature go above 50 °C. 
4. Slowly add 11.6 g of dry β-cyclodextrin into the flask.  This process is very 
exothermic, so do not let the temperature rise above 50 °C during the addition. 
5. Maintain the heat to the flask in the oil bath at 70 °C for 18 hours. 
6. Prepare a 3 M sodium methoxide solution by carefully dissolving 4.2 g of sodium in 
60 mL of methanol with cooling. 
7. After 18 hours, evaporate the reaction mixture down to 100 mL, using a high 
vacuum pump connected to the rotavap. 
8. Slowly add the 3 M solution of sodium methoxide to the reaction flask with cooling 
and stirring. Continue stirring for 15 min.   
9. Pour the reaction mixture into 800mL of methanol. 
10. Filter off the precipitate that is formed, and collect in a beaker. 
11. Dissolve the solid material in approximately 100 mL of DMF, and slowly add to it 
deionized water until cloudiness appears.  Allow the mixture to stand, and more 
solids will form, leaving a clear supernatant liquid.  Filter the solids out, and keep the 
filtrate for additional product recovery.  
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12. Repeat step 11 and monitor the purity of the product by normal phase HPLC, using 
methanol:water 95:5 mobile phase, at a flow rate of 2.0 mL / min.  Typical purity > 
99%. 
 
Synthesis of Heptakis(6-deoxy-6-morpholino)-$-cyclodextrin 
1. Dissolve Heptakis(6-deoxy-6-iodo)-β-Cyclodextrin (dried to a constant weight in the 
vacuum oven at 75 °C) in morpholine in the ratio of 1 g of CD to 17 mL of 
morpholine with stirring. 
2. Place the flask in the oil bath and set the temperature at 65 °C for 24 hours. 
3. Monitor the progress of the reaction by indirect UV-detection CE, using a 20 mM 
acetic acid buffer titrated to pH 4.55 with imidazole as the BE, with the UV-detector 
placed at the cathode. 
4. The reaction is judged complete when the normalized relative peak area of the fastest 
migrating component is > 98%.  Note: this peak migrates very close to the unreacted 
morpholine peak. 
5. Remove the flask from the oil bath and evaporate off the excess morpholine on the 
high vacuum rotovap. 
6. Dissolve the resulting solid in a small amount of deionized water. 
7. Precipitate the solids with acetone, filter by suction using number one filter paper, 
and collect the solids. 
8. Suspend the solids in ethanol using 1g of solids to 7mL of ethanol. 
9. Digest the suspension by gentle heating to remove the brownish color. 
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10. Repeat steps 8 and 9 and monitor the purification by CE until the solids are white.  
Typical purity is about 98%.     
 
Synthesis of Heptakis(6-deoxy-6-morpholinio)-$- cyclodextrin Iodide 
1g scale 
1. Dissolve 1 g of heptakis(6-deoxy-6-morpholino)-$-CD (dried to a constant weight in 
the vacuum oven at room temperature) using 5mL of dry 1-methyl-2- pyrrolidinone 
(NMP) in 25 mL, 3-neck, round bottom flask. 
2. Place a small stir bar into the flask and clamp the flask in the oil bath.  Attach a 
condenser to the flask. 
3. Connect the condenser to a recirculating coolant. 
4. Maintain the temperature of the oil bath at 45 °C. 
5. Dropwise add 3 mL of iodomethane into the reaction flask. 
6. Add 10 mg of sodium carbonate 
7. Monitor the reaction by 1H NMR, using D2Oas the solvent and 500 MHz NMR as 
the instrument, and observe the anomeric 1H around δ 5.2 ppm. 
8. The reaction is judged complete when the multiple peaks in the NMR spectrum at 
about 5.2 ppm have disappeared leaving only one doublet for the anomeric proton. 
9. Evaporate the reaction solvent under reduced pressure at 60°C to obtain a brownish 
paste that dissolves readily in water. 
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10. Precipitate the off-white solids from the aqueous solution with acetone, and 
subsequently recrystallize them from a methanol-ethanol mixture (~ 10 mL/g) to 
obtain the pure product. 
11. Check the purity of the final product by indirect UV-detection CE, using 20 mM 
formic acid/aniline buffer, pH = 3.6, positive to negative polarity. Typical purity is 
about 98%.  
 
Synthesis of Heptakis(6-deoxy-6-morpholinio)-cyclomaltoheptaose Chloride 
(HMBCD) 
1. For a 5 g sample, use a 46 mL volume of a strong anion exchange resin. 
2. Wash the anion exchanger in a beaker several times with deionized water until the 
wash water is clear. 
3. Slowly pack the anion exchange resin in a suitable glass column. 
4. Prepare 40 mL each of 1 M HCl and 1 M NaOH solutions. 
5. Pour the NaOH solution into the column and using deionized water elute it at a rate 
of 1 mL/min.   
6. Check the pH of the effluent with pH paper.  
7. Continue the water wash until the effluent is neutral by pH paper.  For a 5 g scale, 
elute another 20 mL of water after the pH paper first appeared neutral. 
8. Repeat steps 5 to 7 with the acid solution. 
9. Prepare another NaOH solution and repeat steps 5 to 7. 
10. Dissolve the sample in a minimum amount of water and elute through the column. 
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11. Wash the column with deionized water until the effluent is neutral. Combine all the 
effluent.  Collect extra 20 mL of effluent and add it to the sample.  
12. Titrate the collected solution with HCl to neutral pH. 
13. Evaporated the water under reduced pressure at 50 °C to obtain the pure solid 
product. 
 
Synthesis of p-Toluenesulfonyl Anhydride (Ts2O) 
1. Add 500 mL CH2Cl2 into a 500 mL flask. 
2. Dissolve 80 g (0.43 mol) of TsCl and 20 g (0.11 mol) of TsOH.H2O in the 500 mL 
CH2Cl2. 
3. Stir the mixture for 24 hours. 
4. Pour about 250 g of silica gel into a Buchner funnel, and wash with 
dichloromethane, using suction.  Slowly filter the reaction mixture through the silica 
gel.   
5. Reduce the volume of the solution down to 50% by evaporation. 
6. Slowly add hexane to the solution to precipitate pure Ts2O. 
 
Synthesis of Mono(6-O-tosyl)-$-cyclodextrin 
1. Suspend 11.5 g (10 mmol) of native β-CD and 4.9 g (15 mol) of the freshly made 
Ts2O in 250 mL deionized water in a reaction flask. 
2. Stir the suspension for 2 hours. 
3. Add a solution of NaOH (5.0 g in 50 mL of deionized H2O). 
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4. After 10 min, filter off the unreacted Ts2O using a sintered glass funnel. 
5. Add 13.4 g of NH4Cl to the solution to bring its pH to about 8. 
6. Allow the solids to precipitate out overnight at 4 °C. 
7. Siphon off the supernatant liquid. 
8. Wash the solids 2 times by adding 250 mL each of deionized water into the beaker 
containing the product.  Stir the material for a few minutes and allow it to settle.  
Then remove the supernatant liquid.  Repeat the water wash 2 times to be sure that 
all the salts are have been removed. 
9. Repeat the washing procedure with acetone. 
10. Filter and collect the white product using number one filter paper. 
11. Check the purity of the material by TLC using (1) aluminum-backed Silica 60 plates 
and n-propanol : water : ethylacetate : ammonium hydroxide; 5:3:1:1 as the running 
solvent, giving an Rf = 0.68, and (2) an isocratic normal phase HPLC separation, 
using a 4.6 mm I. D.  × 250 mm Zorbax silica column and a 30 : 70, ethylacetate : 
methanol binary mobile phase at 2.0 mL / min, at ambient temperature.  Typical 
purity is about 98%. 
 
Synthesis of Mono(6-deoxy-6-pyridinium)-$-cyclodextrin (CDP) 
1. Add 10g (7.8 mmol) of mono(6-O-tosyl)-$-CD (dried to a constant weight at room 
temperature) into 100 mL of dry pyridine in a 500 mL flask. 
2. Flush the reaction flask with dry nitrogen. 
3. Place the flask on a heating mantle and raise the temperature to 70 °C. 
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4. Monitor the progress of the reaction by direct UV-detection CE, using a 50 mM 
phosphoric acid buffer titrated with lithium hydroxide to pH 2.13 as the BE, with the 
UV-detector placed at the cathode. 
5. The reaction is judged complete when the peak area of the major component >98%. 
6. Remove unreacted pyridine by evaporation, using the high vacuum rotovap. 
7. Dissolve the residue in deionized water, and filter off the undissolved solids. 
8. Collect the filtrate and concentrate it to about 30% of its original volume by 
evaporation. 
9. Precipitate the solid material from the aqueous solution by slow addition of the equal 
volume of acetone, and collect the precipitate by filtration. 
10. Repeat the precipitation procedure 3 times, or until the product becomes white, 
check the purity by CE.  Typical purity > 98%. 
 
Synthesis of Mono(6-deoxy-6-N,N,N’,N’,N’-pentamethylethylenediamino)- $-
cyclodextrin 
 For a 1g scale 
1. In a 3 neck ,50 mL round bottom flask, add 1.0 g (0.78 mmol) of dry mono(6-O-
tosyl)-$-CD, and 10 mL of N,N,N’-trimethylethylenediamine.  Place the reaction 
flask in the oil bath and stir at 60°C. Progress of the reaction can be monitored by 
two complementary methods; (i) indirect UV-detection CE, using a 20 mM acetic 
acid solution, titrated to pH 4.55 with 10 mM imidazole as the BE, and (ii) direct 
UV-detection CE, using 25 mM phosphoric acid titrated to pH 2.55 with lithium 
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hydroxide as the BE to follow the disappearance of the mono-tosylated $-CD that 
shows as a negative peak close to the neutral marker peak. 
2. The reaction is stopped after the mono(6-O-tosyl)-$-CD peak has completely 
disappeared from the electropherogram obtained using the second monitoring 
procedure, which is about 12 hours. 
3. Evaporate the reaction mixture to dryness under reduced pressure. 
4. The resulting solids are dissolved in a minimum volume of water, and precipitated 
by slow addition of ethanol. Repeat the purification procedure 3 times.  Check the 
purity by CE.  Typical purity > 98%.  Dry the product in a vacuum oven at room 
temperature. 
 
Synthesis of Mono(6-deoxy-6-N,N,N’,N’,N’-pentamethylethylenediammonio)-β-
cyclodextrin Iodide. 
1. Dissolve 1 g of mono(6-deoxy-6-N,N,N’-trimethylethylenediamino)-$-CD in 10 mL 
of DMF and obtain a clear solution in a reaction flask. 
2. Slowly add 5 mL of iodomethane into the reaction flask. 
3. Place the flask in the oil bath. Attach a condenser to the flask, and connect the 
condenser to a recirculating coolant.  Raise the temperature to 45 °C. 
4. Monitor the progress of the reaction by indirect UV-detection CE, using a 20 mM 
acetic acid solution, titrated to pH 4.55 with 10 mM imidazole as the BE. 
5. The reaction is judged complete when the relative area of the major component with 
a mobility of about 13 × 10-5cm / Vs is greater than 98%.  
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6. Evaporate the reaction solvent under reduced pressure, and redissolve the residue in 
a minimum volume of deionized water.  Slowly add acetone, about 2 times the 
volume of the aqueous solution, to precipitate the solid product.  Collect the solids 
by suction filtration. 
7. Repeat this procedure until the brownish solids turn to off-white. Check purity by 
CE.  Typical purity >98%. 
 
Synthesis of Mono(6-deoxy N,N,N’,N’,N’-6-pentamethylethylenediammonio)-
cyclomaltoheptaose Chloride (PEMEDA-BCD) 
1. For a 1 g sample, pour 8 mL of the anion exchange resin into the column and rinse 
the column with deionized water. 
2. Dissolve 1 g of NaOH in 20 mL of deionized water, and elute through the column 
with deionized water. 
3. Wash the column with more deionized water until the effluent pH is neutral pH 
paper. 
4. Repeat steps 4 and 5 with HCl. 
5. Then repeat steps 4 and 5 with NaOH. 
6. Dissolve the 1 g of mono(6-deoxy-6-N,N,N’,N’,N’-pentamethylethylenediammonio)-
β-cyclodextrin Iodide in 2 mL of deionized H2O, and pour the solution into the 
column.  Elute through the column with deionized H2O until the effluent is neutral 
by pH paper.  Allow 5 mL extra deionized H2O to elute into the collection beaker 
after the effluent was observed to be neutral. 
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7. Check for the disappearance of iodide by direct UV-detection CE analysis, using a 
25 mM phosphoric acid solution titrated to pH 2.55 with lithium hydroxide as the 
BE, and the detector at 214 nm.  Run the separation with negative to positive 
polarity. 
8. Titrate the basic solution with HCl to pH ~ 7.0 
9. Evaporate water from the solution to obtain the final product. 
10. Analyze the product by MALDI-TOF-MS.  
 
Synthesis of Anionic Analytes 
1. Add 1 g of the starting alcohol and 1.5 mL of DMF into a 25 mL reaction flask with 
stir bar. 
2. Carefully add 1.25 g of sulfur trioxide pyridine complex (98%) into the reaction 
flask, and allow the mixture to stir at room temperature. 
3. Monitor the progress of the reaction by direct UV-detection CE, using a BE 
containing 20 mM boric acid titrated to pH 9.0 with LiOH.  The reaction is stopped 
when there is no more increase in the peak area of the target component. 
4. Evaporate the reaction mixture to a viscous liquid at less than 50 °C. 
5. Redissolve the product in small amount of deionized water, and add a 1 M NaOH 
solution to bring the pH 12 to 12.  Immediately add the solution to an equal volume 
of acetone.  
6. Filter off the sodium salts, using number one filter paper. 
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7. Evaporate the liquid from the solution at not more than 50 °C to collect the final 
product. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 183
 
 
 
VITA 
 
Kingsley C. I. Nzeadibe obtained his B.S. degree in Chemistry from the 
University of Oklahoma, Norman, Oklahoma, in December 1992, and his M.S. degree in 
Chemical Engineering from Louisiana Tech University, Ruston, Louisiana, in February 
1997.   In 2000 Kingsley received the College of Science Dean’s Graduate Scholar 
award from Texas A&M University, College Station, Texas, where he obtained his 
Ph.D. in Chemistry in May 2006. 
During Kingsley’s career at Texas A&M University, his work produced one 
publication in the Electrophoresis and materials for more publications, a dissertation, 
and a patent.  Kingsley also presented his research at both local and international 
conferences. At the 2005 IUCCP symposium, Kingsley received an award for an 
Outstanding Oral Presentation in the Graduate Research in Pharmaceutical Chemistry 
Symposium. 
Kingsley can be reached at Department of Chemistry, TAMU 3255, College 
Station, TX 77843.  
 
